Sommaire

• Symposia SES01. AEP section “Child psychiatry”: Antecedents and mechanisms of mental disorders during childhood and adolescence

  • ·SES01.01 Developmental precursors of affective illness in a general population birth cohort

    Page :213-213

    J. van Os, P. Jones, G. Lewis, M. Wadsworth, R. Murray

    
  • ·SES01.02 Population birth cohorts: Antecedents of schizophrenia

    Page :213-213

    P.B. Jones

    
  • ·SES01.03 Premorbid features of adolescents and young adults with schizophrenia

    Page :213-213

    B. Lahuis

    
  • ·SES01.04 Genesis and course of anxiety and conduct disorders from childhood to early adulthood

    Page :213-214

    M.H. Schmidt, W. Ihle, G. Esser, B. Blanz

    Résumé Résumé Plan Plan

• Symposia S01. The identity and future of psychiatry

  • ·S01.01 The focus and organization of future education

    Page :214-214

    D. Moussaoui

    
  • ·S01.02 Psychiatry: Subspecialisation and relationship with other disciplines

    Page :214-214

    C. Höschl

    
  • ·S01.03 Tasks and requirements for future clinicians

    Page :214-214

    F. Müller-Spahn

    
  • ·S01.04 Evidence based psychiatry and quality management

    Page :214-214

    W. Gaebel

    
  • ·S01.05 The future focus and clinical impact of research

    Page :215-215

    J. Lopez-Ibor

    
  • ·S01.06 The impact and management of financial restriction'

    Page :215-215

    F.L. Mak

    

• Symposia S02. Epsilson study of schizophrenia

  • ·S02.01 Epsilon study of schizophrenia: Cross-cultural adaptation of outcome measures

    Page :215-215

    H.C. Knudsen, J.L. Vázquez-Barquero, B. Welcher

    
  • ·S02.02 Epsilon study of schizophrenia: Outcome measures, care and service costs

    Page :215-215

    D. Chisholm, G. Thornicroft, M. Knapp, T. Becker

    
  • ·S02.03 Epsilon study of schizophrenia: Satisfaction with psychiatric services

    Page :215-215

    M. Ruggeri, A. Lasalvia, R. Dall'Agnola, G. Bisoffi, M. Tansella

    
  • ·S02.04 Epsilon study of schizophrenia: Evaluation of quality of life in european settings

    Page :216-216

    J.L. Vázquez-Barquero, L. Gaite, C. Borra, M. Pérez Retuerto

    

• Symposia S03. Emergent addictive behaviours

  • ·S03.01 Neural substrates of dependence

    Page :216-216

    L. Pulvirenti

    

• Symposia S03. Emergent addictive behaviour

  • ·S03.02 Perseverative behavior: An emerging concept in psychiatric disorders

    Page :216-216

    B.D. Kretschmer

    
  • ·S03.03 Update in pathological gambling

    Page :216-216

    E. Hollander

    
  • ·S03.04 Is OCD a form of addiction?

    Page :216-216

    J. Zohar

    
  • ·S03.05 Kleptomania and compulsive buying: Clinical features of an italian sample

    Page :216-217

    D. Marazziti, C. Pfanner, S. Presta, L. Dell'Osso, G.B. Cassano

    Résumé Résumé Plan Plan

• Symposia S04. Behaviour and motor control in psychiatric disorder

  • ·S04.01 Impulsivity, behavioral dyscontrol, and conscious awareness

    Page :217-217

    E.S. Barratt

    
  • ·S04.02 A new model to assess stimulus processing and behavior control in humans following experimental induction of emotions

    Page :217-217

    M.R. Lemke, T. Wendorff, G. Fritzer, C.J. Fischer, Z. Rupp, S. Tetzlaff

    
  • ·S04.03 Anxiety/aggression-driven depression: A manifestation of serotonergic pathology?

    Page :217-217

    H.M. van Praag

    
  • ·S04.04 Facial expressions and personality

    Page :217-218

    G. Juckel, M. Vogel, A. Präßl, B. Graf, P. Mavrogiorgou, U. Hegerl

    Résumé Résumé Plan Plan

• Symposia S04. Behaviour and motor control in psychiatric disorder

  • ·S04.05 Psychomotor retardation in depression during treatment with SSRI's

    Page :218-218

    B.G.C. Sabbe, W. Hulstijn, M. Pier, F.G. Zitman

    

• Symposia S05. The biology and psychology of memory disorder in schizophrenia

  • ·S05.01 Early memory changes in first episode studies

    Page :218-218

    E. Joyce

    
  • ·S05.02 Charcterisation of the memory defects: Access or versus store disorder

    Page :218-218

    T.K. Kondel

    
  • ·S05.03 Probing semantic memory in schizophrenia

    Page :218-218

    A. David

    
  • ·S05.04 Effect of a subanesthetic dose of ketamine on memory and awareness in healthy volunteers

    Page :218-218

    L.A.B. Hetem, J.M. Danion

    
  • ·S05.05 NMDA deficiency as a basis for the cognitive deterioration in schizophrenia

    Page :219-219

    S.R. Hirsch

    
  • ·S05.06 The neuropathology of schizophrenia dementia

    Page :219-219

    M. Davidson

    

• Symposia W13. Negative attitudes and discrimination against severe mentally ill patients

  • ·W13.01 Stigma in schizophrenia: A German point of view

    Page :219-219

    M.C. Angertneyer

    
  • ·W13.02 Stigma and schizophrenia diagnosis: The opinions of Italian psychiatrists

    Page :219-219

    M. Bassi, I. Tarricone

    
  • ·W13.03 Stigma and the concept of schizophrenia in the third millenium

    Page :219-219

    I.F. Brockington

    
  • ·W13.04 The stigma of schizophrenia and ways of diminishing it

    Page :219-219

    P. Byrne

    
  • ·W13.05 Working with patients and their families: The prevention perspective

    Page :219-219

    A. Fioritti, I. Tarricone

    

• Symposia W07. Interpersonal psychotherapy as individual and group treatment on an affective disorder ward

  • ·W07.01 Interpersonal psychotherapy as individual and group treatment on an affective disorder ward

    Page :220-220

    T. Grüttert

    

• Symposia FC01. Family functioning and abuse

  • ·FC01.01 Social factors and women's mental health in Russia

    Page :220-220

    T. Dmitrieva, M. Kachaeva

    
  • ·FC01.02 False allegations of physical abuse in child: Munchausen by proxy or folie a famillle?

    Page :220-220

    I. Savvidou, V. Bozikas, K. Christianopoulos, A. Karavatos

    
  • ·FC01.03 Influence of moclobemide on sexual performance in patients with psychogenic erectile dysfunction

    Page :220-221

    K. Mann, J. Pankok, J. Leissner, O. Benkert

    Résumé Résumé Plan Plan

• Symposia FC01. Family functioning and abuse

  • ·FC01.04 Family functioning in the families of patients with bipolar and substance use disorders

    Page :221-221

    C.L. Vandeleur, M. Preisig, F. Ferrero

    
  • ·FC01.05 Incestuous relationships in Czech families

    Page :221-221

    P. Pöthe

    
  • ·FC01.06 Prognostic significance of childhood externalising symptoms

    Page :221-221

    M. Gomez-Beneyto, M. Catali, I. Tomis, Y. Ariza, C. Rubio

    

• Symposia ML01. Main lecture 1

  • ·ML01.01 Putting mental health on the European agenda

    Page :221-221

    J. Eskola

    
  • ·PS01.01 Pharmacological and non-pharmacological approaches in the management of recurrent major depressions

    Page :221-222

    G.A. Fava

    Résumé Résumé Plan Plan

• Symposia PS01. Treatment update 2000 — affective disorders

  • ·PS01.02 Pharmacological and non-pharmacological approaches in the management of milder depressions

    Page :222-222

    E.S. Paykel

    
  • ·PS01.03 Pharmacological and non-pharmacological approaches in the long-term management of bipolar disorder

    Page :222-222

    W. Greil, N. Kleindienst

    

• Symposia S06. Evaluation of psychiatric training

  • ·S06.01 Continuing medical (psychiatric) education in Hungary

    Page :222-222

    I. Bitter

    
  • ·S06.02 Evaluation of postgraduate training

    Page :222-222

    I. Tuma

    
  • ·S06.03 Assessment of clinical skills

    Page :223-223

    S.P. Tyrer

    
  • ·S06.04 Examination of psychiatrists in Canada

    Page :223-223

    R. Swinson

    
  • ·S06.05 The future of psychiatric training: What, where, who and how

    Page :223-223

    R. Balon

    

• Symposia S07. Update of genetic research in schizophrenia and affective disorders

  • ·S07.01 Genetic determinants of response to psychopharmacological treatment

    Page :223-223

    M.M. Nöthen

    
  • ·S07.02 Current status of the search for genes contributing to bipolar affective disorder

    Page :223-223

    H. Ewald

    
  • ·S07.03 Current status of the search for genes contributing to schizophrenia

    Page :223-224

    W. Maier, M. Rietschel, D. Lichtermann, D. Müller, T. Schulze, S. Schwab, D. Wildenauer

    Résumé Résumé Plan Plan

• Symposia S07. Update of genetic research in schizophrenia and affective disorders

  • ·S07.04 Joint effects of genotype and environment in schizophrenia

    Page :224-224

    P. Tienari

    
  • ·S07.05 Ethical implications of molecular-genetic research in psychiatry

    Page :224-224

    M. Rietschel

    
  • ·S08.01 Is there a neurochemical basis for alcoholism and relapse? Animal and human studies

    Page :224-225

    R.J. Ward

    Résumé Résumé Plan Plan

• Symposia S08. Pharmacological relapse prevention in alcoholism — from animal models to clinical trials

  • ·S08.02 Pharmacological behaviour aspects and anticraving” substances — Animal studies

    Page :225-225

    J. Wolffgramm

    
  • ·S08.03 Animal models and clinical trials — How do they fit?

    Page :225-225

    O.M. Lesch

    
  • ·S08.04 Clinical efficacy, possibilities and limitations of acamprosate and naltrexone for treating alcohol dependence

    Page :225-225

    J. Chick

    
  • ·S08.05 Pharmacological treatment trials with dopaminergic and serotonergic substances — Myths or facts?

    Page :225-225

    G. Wiesbeck, H.G. Weijers, J.A.L. Boning

    

• Symposia S09. Day hospital specific treatment protocols

  • ·S09.01 Treatment protocol of suicidal behavior in a day hospital setting

    Page :225-225

    M. Sarchiapone, G. Camardese, V. Carli, E. Barbarino, S. De Risio

    
  • ·S09.02 Day hospital eating disorders unit

    Page :225-226

    A. Ciocca

    Résumé Résumé Plan Plan

• Symposia S09. Day hospital specific treatment protocols

  • ·S09.03 Personality disorder treatment

    Page :226-226

    K. Malone

    
  • ·S09.04 A rapid opiate detoxification protocol in D.H. Regimen: Preliminary results

    Page :226-226

    G. Conte, C. Cesaro, D. Catania, S. De Risio

    
  • ·S09.05 Day hospital treatment of mood disorders

    Page :226-226

    M. Sarchiapone, V. Carli, G. Camardese, E. Barbarino, S. De Risio

    

• Symposia S10. Dimensional assessment of personality disorders

  • ·S10.01 The use of behavioral genetic methodology to develop a dimensional measure of personality disorder

    Page :226-226

    K. Jang, J. Livesley

    
  • ·S10.02 The dimensional structure of personality disorder

    Page :226-226

    J. Livesley, K. Jang

    
  • ·S10.03 Personality disorders and the five-factor model of personality — A meta-analysis

    Page :226-227

    F. Ostendorf

    Résumé Résumé Plan Plan

• Symposia S10. Dimensional assessment of personality disorders

  • ·S10.04 Dimensional differentiation between anxiety and depression

    Page :227-227

    W. Peñate

    
  • ·S10.05 Universal validity of dimensional personality (disorder) assessment

    Page :227-227

    R. Pulcrop, E.M. Steinmeyer

    

• Symposia W10. Deinstitutionalisation of former long stay patients in Upper-Austria: a case of success?

  • ·W10.01 Liskal — An instrument for evaluation the deinstitutionalisation and planing psychosocial care

    Page :227-227

    A. Grausgruber

    
  • ·W10.02 The deinstitutionalisation in progress: Some critical results

    Page :227-227

    M. Ortmair

    
  • ·W10.03 Living in the community — Problems and success in view of clients and staff

    Page :227-227

    B. Hloch-Wegscheider

    

• Symposia W12. Video-assisted evidence of recent advances in differentiated psychopathology

  • ·W12.01 The development and heuristic value of Leonhard's classification

    Page :227-227

    G.S. Ungvari

    
  • ·W12.02 The nosological differentiation of catatonia

    Page :228-228

    G. Stöber

    
  • ·W12.03 Nosologic differentiation of postpartum psychoses and the role of reproductive functions for the manifestation of endogenous psychoses in women

    Page :228-228

    B. Pfuhlmann, G. Althaus

    
  • ·W12.04 Motility psychosis: A functional disease of the psychomotor sphere

    Page :228-228

    H. Beckmann

    
  • ·W12.05 The nosological differentiation of paranoid schizophrenia

    Page :228-228

    E. Franzek

    

• Symposia FC02. Dementias and organic disorder

  • ·FC02.01 The pathogenetic role of dopamine in HIV-induced CNS disease

    Page :229-229

    E. Koutsilieri, S. Sopper, S. Czub, V. ter Meulen, E. Riederer

    
  • ·FC02.02 Early and differential diagnosis in mild cognitive impairment, Alzheimer's disease and depression

    Page :229-229

    U. Hegerl, T. Frodl, K. Burger, G. Juckel, H. Hampel, R. Engel

    
  • ·FC02.03 Thyroid function of elderly patients with mental disorders

    Page :229-229

    C.A. de Mendonca Lima

    
  • ·FC02.04 Reduction of psychotic symptoms in patients with lewy body-like symptoms treated with olanzapine

    Page :229-230

    W.S. Clark, J. Street, T. Sanger, A. Breier

    Résumé Résumé Plan Plan

• Symposia FC02. Dementias and organic disorder

  • ·FC02.05 Association of a cathepsin D gene polymorphism with Alzheimer's disease

    Page :230-230

    A. Papassotiropoulos, M. Bagh, F. Jessen, M. Ludwig, M.L. Rao, W. Maier

    
  • ·FC02.06 Obsessive-compulsive disorder and Huntington's disease in a large Italian pedigree

    Page :230-230

    N. De Marchi, M.G. Ariano, R. Mennella, M.A. Ragone, R. Fusco, A. Dama

    
  • ·DE01.01 Borderline personality disorder is a fiction & irrelevant for treatment

    Page :230-231

    M.H. Stone

    Résumé Résumé Plan Plan

• Symposia

  • ·DE01.02 Points concerning the utility of B.P.D.'s relevancy for treatment

    Page :231-231

    H. Sass

    
  • ·PD01.AEP Board of education: Panel discussion on the future of education in Europe

    Page :231-231

    M. Musalek, N. Sartorius

    
  • ·S11.01 From early misconceptions to adult misconceptions

    Page :231-231

    R.M. Murray

    
  • ·S11.02 Transcallosal misconnectivity: The consequence of anomalous lateralization

    Page :231-231

    T.J. Crow

    
  • ·S11.03 The disconnection hypothesis: Theoretical underpinnings

    Page :231-231

    K.J. Friston

    
  • ·S11.04 Using functional neuroimaging to explore connectivity and dysconnectivity in schizophrenia

    Page :231-231

    P. Fletcher

    
  • ·S11.05 Theoretical and methodological considerations for future dysconnectivity research

    Page :232-232

    K. Vogeley

    
  • ·SES02.01 Drug abuse and psychiatric emergencies in developing countries

    Page :232-232

    D. Moussaoui

    
  • ·SES02.02 Crisis interventions in addictions

    Page :232-232

    O.M. Lesch

    
  • ·SES02.03 Emergency drug abuse and security problems: What about treatment?

    Page :232-232

    I. Ferrand

    
  • ·SES02.04 Substance abuse in psychiatric emergencies: The family crisis and its developments

    Page :232-232

    G. Invernizzi

    
  • ·S12.01 Grand rounds: The next generation

    Page :232-232

    R.C. Hsiung

    
  • ·S12.02 Setting up the royal college of psychiatrists' website

    Page :232-233

    D.S. Jago

    Résumé Résumé Plan Plan

• Symposia

  • ·S12.03 Internet and psychiatry: A midsummer night's dream?

    Page :233-233

    M. di Giannantonio, F. Calvosa, S. De Risio

    
  • ·S12.04 Ecology, psychiatry, internet and global environment changes

    Page :233-233

    S. Giuseppe, J. Luigi, L.G. Luca

    
  • ·SES03.01 Biological correlates of emotion in borderline personality disorder

    Page :233-233

    C.S. Herpertz, B. Wenning, T. Dietrich, A. Schuerkens, H. Sass

    
  • ·SES03.02 Neurobiological functioning in families with personality disorders and AXIX-I-disorders

    Page :234-234

    W. Maier

    
  • ·SES03.03 How does 5-HT function relate to impulsivity and aggression in highly aggresssive personality disordered male offenders?

    Page :234-234

    M. Dolan, I. Anderson, B. Deakin

    
  • ·SES03.04 Cognitive and neuropsychological investigations in BPD

    Page :234-234

    A. Andreoli, E. Mayer, Y. Burnand, J.M. Annoni, Th. Landis

    
  • ·C05.01 Cognitive psychotherapy

    Page :234-234

    S. Moorey

    
  • ·C01.01 Brief dynamic psychotherapy

    Page :235-235

    A.A. Dahl

    
  • ·FC03.01 Infertile couples — possibility of cognitive-behavioral therapy in reduction distress

    Page :235-235

    J. Djurkovic-Lazic, B. Lazic, D. Djuric

    
  • ·FC03.02 A cognitive-behavioural group-based intervention for social phobia in schizophrenia

    Page :235-235

    S. Halperin, P. Nathan, P. Drummond, D.J. Castle

    
  • ·FC03.03 Interpersonal psychotherapy: Update for 2000

    Page :235-236

    M.M. Weissman, J. Markowitz

    Résumé Résumé Plan Plan

• Symposia

  • ·FC03.04 The transgenerational psychodynamics of opiate addiction

    Page :236-236

    Zs. Demetrovics

    
  • ·FC03.05 Measuring The ailment”: Perceptions of clinical progress by staff and patients

    Page :236-236

    S.M. Stein

    
  • ·FC03.06 Results of individual psychotherapy of psychosis experienced patients — A 3-years prospective follow-up study

    Page :236-236

    K. Martti

    
  • ·S13.01 The world psychiatric association's consensus statement on the usefulness and use of second generation antipsychotic medications

    Page :236-236

    W.W. Fleischhacker

    
  • ·S13.02 Consensus statements of the world psychiatric association: Rationale, criteria used in selecting topics, utilisation

    Page :237-237

    J. Lopez-Ibor

    
  • ·S13.03 The usefulness and use of second generation antipsychotic medications

    Page :237-237

    N. Sartorius

    
  • ·S13.04 Czech and Slovak meeting on the WPA consensus statement on 2nd generation antipsychotics

    Page :237-237

    J. Libiger

    
  • ·S14.01 Psychotherapy for opiate addicts in methadone substitution — A controlled trial

    Page :237-238

    N. Scherbaum, Th. Finkbeiner, J. Kluwig, D.A. Krause, B. Merget, M. Gastpar

    Résumé Résumé Plan Plan

• Symposia

  • ·S14.02 Pharmacokinetics of methadone and Laam, and their clinical relevance

    Page :238-238

    C.B. Eap, P. Baumann

    
  • ·S14.03 Use abuse and dependence from benzodiazepines in methadone maintained patients — Theoretical and pratical issues

    Page :238-238

    G. Forca, E. Levarta, F. Schifano

    
  • ·S14.04 Methadone substitution therapy (MST): Pattern of service configuration across Europe

    Page :238-238

    H. Ghodse, A. Oyefeso

    
  • ·S15.01 State of the art in psychopharmacological therapy of schizophrenia

    Page :238-239

    F. Müller-Spahn

    Résumé Résumé Plan Plan

• Symposia

  • ·S15.02 New developments in psychosocial rehabilitation of schizophrenia patients

    Page :239-239

    H.D. Brenner

    
  • ·S15.03 Motivational empowerment — A new approach to cognitive rehabilitation in chronic schizophrenia

    Page :239-239

    M. Kuntze

    
  • ·S15.04 Evaluation of a new methodology of cognitive-emotional social skills training programmes for schizophrenic patients

    Page :239-239

    P. Zorn, V. Roder

    
  • ·S15.05 Virtual reality based assessment and therapy for neuropsychological deficits

    Page :240-240

    A.H. Bullinger

    
  • ·S16.01 Neurobiological basis of craving and pleasure experience: One or more reward systems?

    Page :240-240

    W. Zieglgänsberger

    
  • ·S16.02 Craving for opiates

    Page :240-240

    M. Gossop

    
  • ·S16.03 Craving for alcohol

    Page :240-241

    O.M. Lesch, B. König, K. Ramskogler, A. Riegler, A.G. Zoghlami, H. Walter

    Résumé Résumé Plan Plan

• Symposia

  • ·S16.04 Craving for stimulants

    Page :241-241

    L. Janiri

    
  • ·S16.05 Methodological and clinical issues in craving measurement

    Page :241-241

    J. Chick

    
  • ·SES04.01 The concept of hallucinations

    Page :241-241

    P. Berner

    
  • ·SES04.02 Hallucinations as disorders of intersubjectivity

    Page :241-241

    G. Stanghellini

    
  • ·SES04.03 Auditory hallucinations: Mapping the neural network using functional magnetic resonance imaging

    Page :242-242

    S.S. Shergill, M.J. Brammer, S.C.R. Williams, R.M. Murray, P.K. McGuire

    
  • ·SES04.04 Auditory hallucinations and hearing impairment

    Page :242-242

    M. Musalek, B. Hobel, A. Zpghlami, N. Benda, R. Eher, G. Fruhwirt, H. Krudl, A. Neumeister, J. Stössl, S. Zadro-Jaeger

    
  • ·SES04.05 Treatment and outcome in hallucinatory states

    Page :242-242

    S. Opjordsmoen, N. Retterstöl

    
  • ·SES05.01 Operating a secure unit is cooperating

    Page :242-242

    H. van Marle

    
  • ·SES05.02 Forensic security measures in Switzerland: From law to institutions

    Page :242-243

    G. Niveau

    Résumé Résumé Plan Plan

• Symposia

  • ·SES05.03 Psychotherapy process research in therapies with sex offenders in forensic secure units

    Page :243-243

    F. Präfflin

    
  • ·SES05.04 Forensic care in Sweden

    Page :243-243

    F. Hagelbäck-Hansson

    
  • ·FC04.01 Responsiveness of central serotonin receptors in panic disorder: Effects of clomipramine treatment and exercise

    Page :243-243

    A. Broocks, E. Rüther, U. Munzel, G. Hajak, D. Wedekind, B. Bandelow

    
  • ·FC04.02 Deep brain stimulation for severe refractory obsessive-compulsive disorder: A new last-resort therapeutic option?

    Page :243-243

    L. Gabriëls, P. Cosyns, B. Nuttin

    
  • ·FC04.03 Medical utilization and costs in panic disorder

    Page :243-244

    G. Megale, A. Lo Balbo, C. Collazo

    Résumé Résumé Plan Plan

• Symposia

  • ·FC04.04 Pregabalin treatment of generalised anxiety disorder (GAD); three randomised, placebo controlled trials

    Page :244-244

    A.C. Pande, J.G. Crockatt, C. Janney, D.E. Feltner

    
  • ·FC04.05 Personality dimensions and current psychological symptoms nine months after a stressful event (air attacks)

    Page :244-244

    D. Lecic-Tosevski, S. Priebe, J. Gavrilovic, M. Pejovic-Milovancevic, G. Knezevic

    
  • ·FC04.06 Relationship between stressful life experiences and current symptoms after air attacks

    Page :244-244

    J. Gavrilovic, S. Priebe, D. Lecic-Tosevski, M. Pejovic-Milovancevic, G. Knezevic

    
  • ·SAT01.01 Treatment of psychiatric illness: Psychotherapy, pharmacotherapy, anything else?

    Page :245-245

    N. Sartorius

    
  • ·SAT01.02 Pharmacotherapy and psychotherapy: State of the science

    Page :245-245

    M. Lader

    
  • ·SAT01.03 Pharmacotherapy and psychotherapy: State of the art

    Page :245-245

    F. Lelord

    
  • ·SAT01.04 Pharmacotherapy with which psychotherapy?: Results of the espace study

    Page :245-245

    F. Rouillon

    
  • ·S17.01 Functional neuroimaging of cognition: A challenge to neuropsychology

    Page :246-246

    M. Gaviria, D. Medina, Y. Sosa

    
  • ·S17.02 Structural findings in neuropsychiatric disorders: The role of stress

    Page :246-246

    C. Arango, E. Olivares, R. Buchanan

    
  • ·S17.03 Functional imaging in neurodevelopmental disorders

    Page :246-246

    P. Sandor, J. Silveira, D. Mikulis, A. Crawley

    
  • ·S17.04 Insular cortex abnormalities in schizophrenia: Clinical correlates and significance

    Page :246-246

    B. Crespo-Facorro

    
  • ·S18.01 Involuntary, compulsory or coerced treatment: New trends in Belgium

    Page :246-247

    P. Cosyns

    Résumé Résumé Plan Plan

• Symposia

  • ·S18.02 Human rights and compulsive treatment

    Page :247-247

    M. Kastrup

    
  • ·S18.03 Psychiatry and human rights in Romania. Involuntary commitment. 30 years experience

    Page :247-247

    N. Tataru

    
  • ·S18.04 Involuntary commitment in Germany — Ethics, law and practice

    Page :247-247

    N. Nedopil

    
  • ·S18.05 Unvoluntary commitment in France: A model or an exception?

    Page :247-247

    B. Lachaux

    
  • ·SES06.01 Antecedents and early course of affective psychosis

    Page :248-248

    H. Verdoux

    
  • ·SES06.02 Prodromi and early course of schizophrenia and its consequences

    Page :248-248

    W. Löffler, H. Häfner

    
  • ·SES06.03 Predicting the risk of psychosis

    Page :248-248

    K. Maurer

    
  • ·IS01.01 Suicide in adolescents

    Page :248-248

    C. van Heeringen

    
  • ·IS01.02 Suicide in women

    Page :248-249

    I. Brockington

    Résumé Résumé Plan Plan

• Symposia

  • ·IS01.03 Suicide in men

    Page :249-249

    J. Wålinder, W. Rutz, Z. Rihmer, P. Pestality

    
  • ·IS01.04 Suicide in the elderly

    Page :249-249

    E.D. Caine

    
  • ·S19.01 Psychotherapy and cellular function

    Page :249-249

    J. Aldenhoff

    
  • ·S19.02 Psychotherapy and neuroimaging: Effect of cognitive and behavioural therapy on orbito-frontal-subcortical circuits in obsessive-compulsive disorder

    Page :249-249

    F. Hohagen

    
  • ·S19.03 Spet studies on outcome of treatment by psychosocial interventions in depression and hysterical paresthesia

    Page :249-249

    J. Lehtonen, J. Kuikka, H. Viinamäki, J. Tiihonen, M. Husso-Saastamoinen

    
  • ·S19.04 Psychopharmacology and psychotherapy affect the same brain structures

    Page :250-250

    F.A. Henn, E. Edwards

    
  • ·S20.01 Sexual disorders: Diagnostic and epidemiological issues

    Page :250-250

    R.T. Segraves

    
  • ·S20.02 Sexual dysfunction and psychopathology in the elderly

    Page :250-250

    D. Aizenberg

    
  • ·S20.03 Psychological aspects of sexual disorders

    Page :250-251

    K. Segraves

    Résumé Résumé Plan Plan

• Symposia

  • ·S20.04 Biological treatments of paraphilias and premature ejaculation

    Page :251-251

    R. Balon

    
  • ·S20.05 Treatment of sexual dysfunction associated with medication

    Page :251-251

    Z. Zemishlany

    
  • ·S21.01 Cognitive rehabilitation in psychiatric patients

    Page :251-252

    H.D. Brenner

    Résumé Résumé Plan Plan

• Symposia

  • ·S21.02 Cognitive dysfunctions in psychotic patients: Relationship with symptoms and antipsychotic treatment

    Page :252-252

    S. Galderisi, A. Mucci, M. Maj

    
  • ·S21.03 Hemispheric asymmetries and psychotism

    Page :252-252

    J. Gruzelier

    
  • ·S21.04 A neurophysiological framework for psychosis

    Page :252-252

    M. Koukkou

    
  • ·W03.01 Problems of the undergraduate training in psychiatry in the Czech Republic

    Page :252-253

    J. Libiger, I. Tuma

    Résumé Résumé Plan Plan

• Symposia

  • ·W03.02 Undergraduate studies in psychiatry in the problem-based learning medical curriculum at university of tampere

    Page :253-253

    R. Kaltiala-Heino, A. Pasternack

    
  • ·W03.03 Education in liaison psychiatry

    Page :253-253

    M. Musalek, B. Hobl, U. Mossbacher, A. Zoghlami

    
  • ·W03.04 Education & training in psychiatry in Europe: Undergraduate teaching and training in Turkey

    Page :253-254

    V. Sar

    Résumé Résumé Plan Plan

• Symposia

  • ·W03.05 Toward better public mental health by means of problem oriented and community based mental health education

    Page :254-254

    M.W. deVries

    
  • ·W03.06 Psychiatric education and the changing undergraduate curriculum in the UK

    Page :254-254

    M. Greenberg

    
  • ·FC05.01 The association between one-year outcome of major depression and care utilisation in the general population. Findings from The Netherlands mental health survey and incidence study (Nemesis)

    Page :254-254

    J. Spijker, R.V. Bijl, R. de Graaf, W.A. Nolen

    
  • ·FC05.02 Psychopathology and treatment prognosis in BDV-infected patients

    Page :254-255

    C.W. Spannhuth, D.E. Dietrich, L. Bode, T. Lau, T.J. Huber, H. Ludwig, H.M. Emrich

    Résumé Résumé Plan Plan

• Symposia

  • ·FC05.03 Familial relationship between bipolar I disorder and attention-deficit/hyperactivity disorder

    Page :255-255

    M. Preisig, F. Ferrero

    
  • ·FC05.04 Influence of pharmacologically different antidepressants on neurocognition of patients with depressive disorders

    Page :255-255

    N.-U. Neumann, St. Bretschneider, Ch. Bullacher, K. Frasch, R. Hess, R. Wittek

    
  • ·FC05.05 A genome-wide scan in 10 multiplex families with bipolar disorder

    Page :255-255

    S.J. Claes, A. Patterson, J. Del-Favero, S. Van Gestel, J. Mendlewicz, F. Macciardi

    
  • ·FC05.06 Harm avoidance and 5-HT2A receptors in depression

    Page :256-256

    H.A.H. D'haenen, A. Van Mol, C. Vanhove, J. Mertens, K. Chavatte, D. Terriere

    
  • ·ML02.01 Growing together in diversity

    Page :256-256

    N. Sartorius

    
  • ·PS02.01 Social phobia

    Page :256-256

    Y. Lecrubier

    
  • ·PS02.02 Panic disorder

    Page :256-256

    A.A. Dahl

    
  • ·PS02.03 Somatization disorder

    Page :256-256

    S. Wessely

    
  • ·PS02.04 Post-traumatic stress disorder

    Page :256-256

    L. Weisæth

    
  • ·S22.01 Psychotherapy in psychiatry

    Page :256-256

    K.C. Treichel

    
  • ·S22.02 Global priorities in psychiatry

    Page :256-256

    J.L. Ayoso

    
  • ·S22.03 The rise of biological psychiatry

    Page :256-256

    M. Eronen

    
  • ·S22.04 Deinstitutionalisation

    Page :257-257

    P. Munk-Jørgensen

    
  • ·S22.05 Psychiatry in Eastern Europe

    Page :257-257

    X. Solozhenkina

    
  • ·SES07.01 How to manage early intervention

    Page :257-257

    J. Klosterkötter

    
  • ·SES07.02 Cognitive treatment in early psychotic breakdown

    Page :257-257

    P.A. Garety

    
  • ·SES07.03 Early detection and intervention in psychosis, the stavanger model

    Page :257-257

    J.O. Johannessen

    
  • ·SES08.01 Quality of life — a new concept and its measurement

    Page :257-257

    H. Katschnig

    
  • ·SES08.02 The SF-36 in an observational study of alcohol dependent patients treated with acamprosate

    Page :257-257

    P. Lehert, F. Landron

    
  • ·SES08.03 Application of quality of life measures to alcohol misusers

    Page :258-258

    T.J. Peters, J. Foster

    
  • ·SES08.04 Quality of life in institutionalized alcoholics with psychiatric comorbidity

    Page :258-258

    M. Berglund, B. Sallmén, B. Bokander

    
  • ·SES08.05 Quality of life, drinking and smoking in alcoholics 7 years after treatment

    Page :258-258

    K. Mann, K. Ackermann

    
  • ·S23.01 Changes in gene expression during TMS

    Page :258-258

    T.E. Schlaepfer

    
  • ·S23.02 Revealing abnormalities in cortical excitability in depressive disorders with TMS

    Page :258-258

    F. Maeda

    
  • ·S23.03 Functional neuroimaging during TMS

    Page :258-258

    K.P. Ebmeier

    
  • ·S23.04 Monitoring TMS with EEG and MEG

    Page :259-259

    R. Ilmoniemi

    
  • ·S23.05 Do changes in cortical output maps correlate with clinical response during TMS in patients with MDD?

    Page :259-259

    L. Grunhaus

    
  • ·SES09.01 Violence as a public health issue. The contribution of psychiatrists to an integrated multidimensional approach

    Page :259-259

    A. Andreoli

    
  • ·SES09.02 When violence is a psychiatric disorder

    Page :259-259

    M. Furlan

    
  • ·SES09.03 Violence in psychiatric institutions in developing countries

    Page :259-259

    D. Moussaoui

    
  • ·W01.01 Attitudes of the general population concerning schizophrenia

    Page :259-259

    A. Grausgruber

    
  • ·W01.02 Attitude starts in school. A programme in approach to reduce stigma in schools

    Page :259-259

    U. Meise

    
  • ·W01.03 Why is it important for Austria to establish an anti-stigma-programme on schizophrenia?

    Page :259-259

    W.W. Fleischhacker

    
  • ·W01.04 Activities of fighting stigma: An example of a regional campaign

    Page :259-260

    W. Schöny

    Résumé Résumé Plan Plan

• Symposia

  • ·W14.01 The epidemiology of suicide

    Page :260-260

    E. Szadoczky

    
  • ·W14.02 Biological factors in suicide

    Page :260-260

    C.M. Bánki

    
  • ·W14.03 Social factors and psychotherapy in suicide

    Page :260-260

    F. Füredi

    
  • ·W14.04 Pharmacological treatment and prevention in suicide

    Page :260-260

    Z. Rihmer

    
  • ·W14.05 Suicide in slovenia from 1970 to 1997

    Page :260-260

    S. Ziherl, B. Zalar

    
  • ·FC06.01 Regulation of serotonin transporter trafficking by treatment in human platelets

    Page :260-260

    K.Y. Little, L. Zhang, A. Shakoor

    
  • ·FC06.02 First results of fluvoxamine versus lithium aggressivity protocol (FLAP)

    Page :261-261

    G. La Malfa, M. Bertilli, M. Conte, P. Cabras

    
  • ·FC06.03 Association of serotonin transporter promoter gene variants with clinical features of major depression

    Page :261-261

    A. Putzhammer, P. Eichhammer, T. Rohrmeier, H. Sartor, L. Angermueller, P. Dallinger, U. Frick, H.E. Klein, A. Schoeler

    
  • ·FC06.04 Spect imaging of 5-HT_2A receptors during SSRI treatment

    Page :261-261

    H. D'haenen, P. Lezaire, C. Vanhove, J. Mertens, K. Chavatte, D. Terriere, A. Bossuyt

    
  • ·FC06.05 Multiparametric biomonitoring of autonomic functions in patients treated with psychotropic drugs

    Page :261-262

    M. Mueck-Weymann, J. Acker, T. Rechlin, R. Rauh, P. Joraschky

    Résumé Résumé Plan Plan

• Symposia

  • ·FC06.06 Decreased serotonin 5-HT2A binding potential in patients with anorexia nervosa

    Page :262-262

    K. Titeca, K. Audenaert, K. Van Laere, F. Dumont, M. Vervaet, G. Slegers

    
  • ·DE02.01 Has dynamic psychiatry a future?

    Page :262-262

    A.A. Dahl, D. Goldberg

    
  • ·SES10.01 Epidemiology of dementia and cognitive impairment: recent developments

    Page :262-262

    C. Brayne

    
  • ·SES10.02 Eurocare: A cross-national study of co-resident spouse carers for people with Alzheimer's disease

    Page :262-263

    J. Murray, S. Banerjee, J. Schneider, A. Mann

    Résumé Résumé Plan Plan

• Symposia

  • ·SES10.03 Special care units for demented patients

    Page :263-263

    G.B. Frisoni

    
  • ·SES10.04 The burden of care among nurses in homes for the elderly

    Page :263-263

    S. Weyerer

    
  • ·S24.01 Are the dermatoglyphic findings in schizophrenia specific markers of the disorder? Results from a sample of mentally healthy adult survivors of very low birthweight

    Page :263-263

    P. Fearon, L. Fañanás, M. Taylor, L. Rifkin, R. Murray

    
  • ·S24.02 Is there recognisable neurocognitive profile associated with dermatoglyphic anomalies in psychosis?

    Page :263-264

    A. Rosa, F. Serrano, A. Zarzuela, A. Martinez-Larrea, M. Cuesta, V. Peralta, L. Fañanás

    Résumé Résumé Plan Plan

• Symposia

  • ·S24.03 Can the dermatoglyphic evidence be validated by MRI images?

    Page :264-264

    J. van Os

    
  • ·S24.04 Associations between dysmorphic features, dermatoglyphics and lateralisation in psychosis

    Page :264-264

    A. Lane, J. Reilly, O. McTigue, P. Fearon, M. Byrne, C. Larkin, E. O'Callaghan

    
  • ·S24.05 Association between cerebral structural abnormalities and dermatoglyphic ridge counts in schizophrenia

    Page :264-264

    J. van Os, P. Woodruff, L. Fañanas, F. Ahmad, N. Shuriquie, R. Howard, R.M. Murray

    
  • ·S25.01 The epsilon study of schizophrenia in five European countries

    Page :264-264

    T. Becker, M. Knapp, H.C. Knudsen, A. Schene, M. Tansella, G. Thornicroft, J.L. Vazquez-Barquero

    
  • ·S25.02 The prevention of crime and violence among the mentally ill

    Page :264-265

    S. Hodgins

    Résumé Résumé Plan Plan

• Symposia

  • ·S25.03 The behavioural psychopathology of blood disorders. A cross-national study

    Page :265-265

    I. Kolvin, H. Sadowski, C. Clemente, B. Taylor, C.A. Lee, J. Tsiantis, S. Baharaki, M. Mannuci, G. Ba

    
  • ·S25.04 The euro-MDSBL project: Developing common standards for the assessment of disablement in mental and neurological patients in six European countries

    Page :265-265

    V. Mavreas, C. Pull, R. Jenkins, H.W. Hoek, C. Caltagirone, J.L. Vasquez-Barquero, T.B. Ustun

    
  • ·S26.01 The interrelationship between amino acids and β-carbolines

    Page :265-266

    D. Fekkes, L. Pepplinkhuizen

    Résumé Résumé Plan Plan

• Symposia

  • ·S26.02 Acute polymorphous psychosis due to endogenic synthesis of β-carbolines

    Page :266-266

    L. Pepplinkhuizen, D. Fekkes

    
  • ·S26.03 The hallucinations-inducing effect of β-carbolines

    Page :266-266

    H. Rommelspacher, C. Spies, J. Dierkes

    
  • ·S26.04 Amino acids and norharman in depression and panic disorder

    Page :266-266

    L. Timmerman, D. Fekkes, L. Pepplinkhuizen

    
  • ·S26.05 Norharman in mentally retarded patients

    Page :267-267

    S. Tuinier, W.M.A. Verhoeven, L. Pepplinkhuizen, D. Fekkes

    
  • ·S27.01 Longterm course of bipolar disorder

    Page :267-267

    J. Angst, F. Angst, R. Sellaro, H. Zhang

    
  • ·S27.02 Persistent dysregulations in pure BP-1 disorder versus mixed states

    Page :267-267

    G. Perugi

    
  • ·S27.03 Polarity congruency between affective temperaments and major episodes in mood disorders

    Page :267-267

    E.-G. Hantouche

    
  • ·S27.04 Prospective assessment of affective temperaments in a cohort of juvenile depressives

    Page :268-268

    F.J. Kochman, E.G. Hantouche, J.A. Meynard, G. Hamm, D. Bayart

    
  • ·S27.05 Temperamental dysregulations in mood disorders

    Page :268-268

    H.S. Akiskal

    
  • ·C04.01 Psychiatrists and the media

    Page :268-268

    O. Cuenca, A.W. Clare

    
  • ·C03.01 Human brain imaging course

    Page :268-269

    G. Sedvall

    Résumé Résumé Plan Plan

• Symposia

  • ·FC07.01 Novelry seeking and harm avoidance dimensions in the prediction of suicide attempt behavior among psychiatric patients

    Page :269-269

    S. Gil

    
  • ·FC07.02 The experience of patient suicide among trainees in psychiatry

    Page :269-269

    K.P. Courtenay, J.P. Stephens

    
  • ·FC07.03 Suicide behavior in Russia in 1980–1990S: Indices and factors

    Page :269-269

    V. Krasnov, V. Voitsekh, A. Nemtsov

    
  • ·FC07.04 Borderline personality disorder and suicide

    Page :269-269

    J.J. McCutchan, O. Junker

    
  • ·FC07.05 Attitudes of medical students towards suicide

    Page :270-270

    O. Kulśková, T. Urbánek

    
  • ·FC07.06 A case control study of suicide amongst persons not involved with mental health services

    Page :270-270

    K.R. Lloyd, N.J. Booth, C.V. Owens

    
  • ·S28.01 Changes in ABETA4 plasma levels and other markers: Results from a comprehensive multicenter study of peripheral bilogical and neuropsychological variables in early Alzheimer's disease

    Page :270-270

    P.J. Rogue

    
  • ·S28.02 Clinicaopathological correlations and the differential diagnosis of dementias

    Page :270-270

    C. Derouesne

    
  • ·S28.03 Neuroimaging in Alzheimer's disease

    Page :270-270

    J. de Groot

    
  • ·S28.04 Biochemical markers and the diagnosis of Alzheimer's disease — Overview

    Page :270-270

    M. Novak

    
  • ·S28.05 Increased CSF levels of a presenilin I loop fragment in sporadic Alzheimer's disease: Possible biological marker

    Page :270-270

    R. Nitsch

    
  • ·ISO2.01 Fighting stigmatisation because of schizophrenia in spain: results

    Page :271-271

    J.J. Lopez-Ibor

    
  • ·ISO2.02 Fighting stigma and discrimination because of schizophrenia

    Page :271-271

    N. Sartórius

    
  • ·ISO2.03 Combining a programme against stigma with a comprehensive research programme on schizophrenia

    Page :271-271

    W. Gaebel

    
  • ·IS02.04 The Austrian programme on fighting stigma because of schizophrenia

    Page :271-271

    W. Schöny

    
  • ·IS02.05 Anti-stigmatisation programme in ITALY

    Page :271-272

    G. ossi

    Résumé Résumé Plan Plan

• Symposia

  • ·IS02.06 Anti-stigmatisation programme in GREECE

    Page :272-272

    C.N. Stefanis, M. conomou

    
  • ·S29.01 Biomed-merope project for adults with psychiatric disorders and mental retardation

    Page :272-272

    N. Bouras, G. Holt, J. Hillery, L. Salvador, J. Tsiantis, G. eber

    
  • ·S29.02 A European technology for comparing mental health care systems. Adaptation, validation and application in a large sample of Italian catchment areas

    Page :272-272

    G. Tibaldi, C. Munizza, E. Scala, C. Palazzi, M. Zuccolin, S. Cesano, G. Fantini, R. Dazzi, C. Testa

    
  • ·S29.03 The family of the schizophrenic patient: Objective and subjective burden and coping strategies

    Page :273-273

    L. Maglianol, G. Fadden, J.M. Caldas de Almeida, M. Madianos, T. Held, M. Maj

    
  • ·S30.02 Behavioural pharmacology of MDMA in nonhumans

    Page :273-273

    C.-E. Johanson

    
  • ·S30.02 Effects of MDMA (ecstasy) on sensorimotor gating (prepulse inhibition) in humans after pretreatment with citalopram, haloperidol, or ketanserin

    Page :273-273

    F.X. Vollenweider, M.E. Liechti, M. Geyer, D. Hell

    
  • ·S30.03 Subjective and reinforcing effects of MDMA and mCPP compared to d-amphetamine in humans

    Page :273-273

    M. Tancer, C.-E. Johanson

    
  • ·S30.04 Functional brain imaging after acute and chronic exposure to MDMA (ecstasy”)

    Page :273-273

    A. Gamma, A. Buck, T. Berthold, M.E. Liechti, F.X. Vollenweider

    
  • ·SES11.01 Causality of personality disorders and therapeutic intervention: A review of the psychoanalytic literature, 1908–1990

    Page :273-273

    F. Sauvagnat

    
  • ·SES11.02 Emerging from borderline state of mind: Psychoanalytic view

    Page :273-273

    M. Sebek

    
  • ·SES11.03 Repairing the trauma: The internalization of the analytic relationship by the borderline patient

    Page :273-274

    Z. Christos

    Résumé Résumé Plan Plan

• Symposia

  • ·SES11.04 Psychotherapy of suicidal patients

    Page :274-274

    D. Cremniter

    
  • ·SES11.05 Sojourn in the psyche: some effects of (borderline patients') projective identifications

    Page :274-274

    G. Vaslamatzis

    
  • ·FC08.01 Personality disorders and early development in female offenders

    Page :274-274

    M. Kachaeva, T. Dmitrieva

    
  • ·FC08.02 Ethnocultural peculiarities of suicide prevalence in RUSSIA

    Page :274-275

    B. olozhy

    Résumé Résumé Plan Plan

• Symposia

  • ·FC08.03 Peculiarities of socially dangerous behavior of the mentally ill in modern Russia

    Page :275-275

    T. Dmitrijeva, Z. olozhaya

    
  • ·FC08.04 Impact of depression, impulsivity and recent life-events in first-time and repeat suicide attempts

    Page :275-275

    M. Benoit, M. Jaubert, F. Askenazy, P.H. Robert, D. Pringuey, G. arcourt

    
  • ·FC08.05 ADHD as a risk factor for sexual delinquency

    Page :275-275

    D. Blocher

    
  • ·FC08.06 Mentally disordered offenders in Britain: Current practice and future proposals

    Page :275-275

    C.S.H. Brown

    
  • ·SES12.01 Women and organised violence

    Page :276-276

    M. Kastrup

    
  • ·SES12.02 Genetics of puerperal psychosis

    Page :276-276

    I. Jones

    
  • ·SES12.03 Danish national studies of postpartum mental illness

    Page :276-276

    I.M. Terp, P.B. Mortensen, G. Engholm, H. Møller

    
  • ·SES12.04 Psychiatry of the menopause

    Page :276-276

    G. olnar

    
  • ·SES12.05 Psychiatry of female criminality

    Page :276-276

    T. Dmitrieva

    
  • ·SES12.06 Obstetric liaison services

    Page :276-276

    A. Rohde

    
  • ·S31.01 History and current development in CZECH psychiatry

    Page :276-277

    J. Raboch

    Résumé Résumé Plan Plan

• Symposia

  • ·S31.02 The pros and cons of a czech education: Experience of a Norwegian psychiatrist Experience of a Norweigian psychiatrist

    Page :277-277

    A. Restan

    
  • ·S31.03 The history of czech psychopharmacology and psychopharmacotherapy of affective and schizophrenic disorders

    Page :277-277

    J. Svestka

    
  • ·S31.04 Search for genes for bipolar disorder: The Czech-Canadian connection Cze-Canadian connection

    Page :277-277

    M. Alda, P. Zvolský, P. Grof

    
  • ·S32.01 New antipsychotics: Symptoms and clinical course

    Page :277-278

    W. Gaebel

    Résumé Résumé Plan Plan

• Symposia

  • ·S32.02 Quality of life and new antipsychotic medications in schizophrenia

    Page :278-278

    A.G. Awad

    
  • ·S32.03 New antipsychotics: The issue of side-effects

    Page :278-278

    W.W. Fleischhacker

    
  • ·S32.04 Pharmacotherapy and the interaction with psychosocial treatment psychosocial treatment

    Page :278-278

    W. Rössler

    
  • ·S32.05 Economics of new antipsychotics

    Page :278-278

    M. Knapp

    
  • ·S33.01 Genetics of suicidal behaviour

    Page :278-278

    W. Maier

    
  • ·S33.02 Biological markers for suicidal behaviours in alcoholics

    Page :278-278

    P. Gorwood

    
  • ·S33.03 The biology of suicide: the dimensional versus the diagnostic correlates

    Page :278-279

    J.J. Mann

    Résumé Résumé Plan Plan

• Symposia

  • ·S33.04 Suicide and young people

    Page :279-279

    B.S. Runeson

    
  • ·S34.01 Midazoline receptors: Potential markers for depression and targets of antidepressant drug development

    Page :279-279

    A. Halaris, J.E. Piletz

    
  • ·S34.02 Cloning of a candidate imidazoline receptor CDNA from human hippocampus

    Page :279-279

    J.E. Piletz, M. Chen, M.E. Lutrick, H. Zhu, J. Baldwin

    
  • ·S34.03 Brain and platelet imidazoline receptors in mood disorders

    Page :279-280

    J.A. Garcia-Sevilla, P.V. Escribá, J. Guimón

    Résumé Résumé Plan Plan

• Symposia

  • ·S34.04 Imaging noradrenergic and non-adrenergic binding of [³H]clonidine in brains from psychiatrically characterized humans

    Page :280-280

    G.A. Ordway, G. Rajkowska, H. Zhu, B.J. Duncan, C.A. Stockmeier, G. Dilley, L. Konick, H.Y. Meltzer, J.C. Overholser, J.E. Piletz, A. Halaris

    
  • ·S34.05 New approaches to imidazoline receptors

    Page :280-280

    D.J. Nutt, R. Price, R. Tyacke, S. Husbands, J. Lewis, D. Finn, M. Lalies, A.L. Hudson

    
  • ·S35.01 Somatoform disorders and concurrent concepts in internal medicine

    Page :280-280

    N. Sartorius, A. Janca

    
  • ·S35.02 Genetic basis of somatoform disorders

    Page :281-281

    W. Maier

    
  • ·S35.03 Chronic fatigue syndrome: Is it a virus or not?

    Page :281-281

    S. Wessely

    
  • ·S35.04 Genetics and pathophysiology of the fibromyalgia syndrome

    Page :281-281

    M. Ackenheil, M.J. Schwarz, B. Bondy, M. Offenbaecher, M. Späth

    
  • ·W04.01 Informed consent, ethical questions

    Page :281-281

    L. Jacobsson

    
  • ·W04.02 Ethical problems with a health database legislation

    Page :282-282

    T. Helgason

    
  • ·W04.03 Ethical review of psychiatric research protocols

    Page :282-282

    M. Lader

    
  • ·W04.04 Ethical questions in genetic psychiatric studies

    Page :282-282

    W. Maier

    
  • ·W04.05 Ethics of psychiatric postmortem brain research

    Page :282-282

    D. Radu, G. Sedvall

    
  • ·W11.01 Clinical application of hypnotherapy

    Page :282-282

    V.M. Mathew

    
  • ·W11.02 Various hypnotic techniques

    Page :282-282

    M. Joseph

    
  • ·W11.03 Practical demonstration and group induction

    Page :283-283

    U. James

    
  • ·W11.04 Structure and functions of British hypnotherapy examinations board

    Page :283-283

    L. Mathew

    
  • ·FC09.01 Binocular rivalry is slow in bipolar disorder but not in schizophrenia or major depression

    Page :283-283

    S.M. Miller, G.B. Liu, T.T. Ngo, L.B. Geffen, B.D. Gynther, P.B. Mitchell, J.D. Pettigrew

    
  • ·FC09.02 The Calgary depression rating scale for schizophrenia (CDSS): Reliability and validity data of a German version

    Page :283-283

    M.J. Müller, O. Benkert

    
  • ·FC09.03 Estabilishing onset in first episode psychosis: The Nottingham onset schedule (NOS)

    Page :283-284

    S.P. Singh, J.E. Cooper, C.J. Tarrant, H. Bagalkote, P.B. Jones

    Résumé Résumé Plan Plan

• Symposia

  • ·FC09.04 The prodrome of first onset psychoses: Are affective symptoms specific to diagnosis?

    Page :284-284

    C.J. Tarrant, S.P. Singh, J.E. Cooper, T. Lloyd, P.B. Jones

    
  • ·FC09.05 Clozapine, olanzapine, risperidone, and haloperidol in refractory schizophrenia

    Page :284-284

    P. Mohr, J. Volavka, J.A. Lieberman, P. Czobor, J. McEvoy, J.-P. Lindenmayer, L. Citrome, B. Sheitman

    
  • ·FC09.06 Cholecystokinin CCK_b receptor mRNA Isoforms: Expression in postmortem monkey and human brain - alterations following schizophrenia

    Page :284-285

    N.L.D. Radu, O. Zachrisson, J. de Belleroche, K.R. Wendt, S. Hirsh

    Résumé Résumé Plan Plan

• Symposia

  • ·ML03.01 Malignant sadness - The evolutionary psychology of depression

    Page :285-285

    L. Wolpert

    
  • ·PS03.01 Treatment of alzheimer's disease

    Page :285-285

    J.T. O'Brien

    
  • ·PS03.02 Treatment of behavioural symptoms in dementia

    Page :285-285

    H. Förstl

    
  • ·PS03.03 Treatment of the dementia disease process

    Page :285-285

    S. Lovestone

    
  • ·SES13.01 Possibilities and limitations in unification of of standards - the challenge in child and adolescent psychiatry

    Page :285-285

    M. Dabkowski

    
  • ·SES13.02 Outcome of childhood separation anxiety disorder

    Page :285-285

    D. Bailly

    
  • ·SES13.03 Grief work and adolescent development

    Page :285-285

    A. Barbosa

    
  • ·SES13.04 Quality of attachment in adolescents hospitalized in crisis unit hospitalized in crisis unit

    Page :285-285

    V. Delvenne

    
  • ·SES13.05 The trauma of separation for anorexic patients: An etiopathogenic agent and a support for treatment

    Page :285-285

    J.L. Venisse

    
  • ·S36.01 A comparison of the utility of dimensional and categorical representations of psychosis

    Page :286-286

    J. van Os, C. Gilvarry, R. Bale, E. van Horn, T. Tartan, I. White, R. urray

    
  • ·S36.02 Psychosis is better described as a continuum, rather than as categories

    Page :286-286

    P.K. McGuire, T.A. Dixon

    
  • ·S36.03 Delusions in the general population

    Page :286-286

    H. Verdoux, J. van Os, S. Maurice-Tison, B. Gay, R. Salamon

    
  • ·S36.04 First rank symptoms in schizophrenia: No basis in evidence

    Page :287-287

    V. Peralta, M.J. Cuesta

    
  • ·S36.05 Are schizophrenics cognitively impaired manics?

    Page :287-287

    R.M. Murray

    
  • ·S37.01 Psychological autopsy studies

    Page :287-287

    E.T. Isometsä

    
  • ·S37.02 The influence of comorbidity on the prevalence of suicidal behaviour

    Page :287-287

    Y. Lecrubier

    
  • ·S37.03 Suicide attempts in placebo controlled trials

    Page :287-287

    T. Laughren

    
  • ·S37.04 The efficacy of psychosocial and pharmacological treatment following deliberate self-harm: a systematic review

    Page :287-288

    K. Hawton

    Résumé Résumé Plan Plan

• Symposia

  • ·SES14.01 From receptor pharmacology to clinical prescription: antidepressants

    Page :288-288

    F. Bengtsson

    
  • ·SES14.02 From receptor pharmacology to clinical prescription: antipsychotics

    Page :288-288

    J. ibert-Rahola

    
  • ·SES14.03 Practical problems with co-prescription: Problems with efficacy

    Page :288-289

    M. Ackenheil

    Résumé Résumé Plan Plan

• Symposia

  • ·SES14.04 Practical problems with co-prescription: Problems with side effects

    Page :289-289

    L.K.M. Jaime, M. Ackenheil

    
  • ·SES14.05 Transnosological prescription

    Page :289-289

    D. Marazziti

    
  • ·W06.01 Concept, structure, and function of the German research network on schizophrenia

    Page :289-289

    W. Wölwer, W. Gaebel

    
  • ·W06.02 Early detection and intervention in populations at risk

    Page :289-289

    H. Häfner, J. Klosterkötter

    
  • ·W06.03 New pharmacological treatment strategies: Acute first episode schizophrenia, non-response and predominant negative symptoms

    Page :289-289

    H.J. Möller

    
  • ·W06.04 Long-term treatment of first episode schizophrenia: New strategies, prodromal symptoms and biological basis of relapse

    Page :290-290

    W. Gaebel

    
  • ·W06.05 New strategies in prevention and rehabilitation of residual schizophrenia

    Page :290-290

    S. Klingberg, O. Buchkremer

    
  • ·W06.06 Molecular-genetic predictors of illness manifestation, course, and treatment response

    Page :290-290

    W. Maier, M. Ackenheil, M. Rietschel, T. Bayer

    
  • ·W08.01 An educational program for the prevention of drug abuse in a high - school

    Page :290-290

    E. Koumbi

    
  • ·W08.02 Early prevention of drug abuse: Methodological and conceptual considerations

    Page :290-290

    E. Tempesta

    
  • ·W08.03 The planning and implementation of primary prevention programmes in schools. Evidence based reconsideration

    Page :290-290

    C. Kröger

    
  • ·W08.04 Methodological and ethical limitations of school based addiction prevention

    Page :291-291

    R. Müller

    
  • ·FC10.01 Outcome of patients with severe mental illness and borderline intellectual functioning

    Page :291-291

    A. Hassiotis, O. Ukoumunne, S. Byford, P. Tyrer, K. Harvey, J. Piachaud, C. Gilvarry

    
  • ·FC10.02 Deinstitutionalisation, living situation and subjective satisfaction of schizophrenic patients

    Page :291-291

    Th.W. Kallert, M. Leiße

    
  • ·FC10.03 A contolled clinical trial of intensive home treatment for persons with severe mental illness

    Page :291-292

    K.R. Lloyd, M. Cleary, C. Pearson, R. Brooks

    Résumé Résumé Plan Plan

• Symposia

  • ·FC10.04 Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres

    Page :292-292

    D. Wiersma, J. Wanderling, E. Dragomirecka, K. Ganev, G. Harrison, W. an der Heiden, F.J. Nienhuis, D. Walsh

    
  • ·FC10.05 Do community based mental health care networks neglect mentally ill homeless people?

    Page :292-292

    H.J. Salize

    
  • ·FC10.06 What is a psychiatrist? What are they really doing? A qualitative study combining focus groups and work sampling

    Page :292-292

    M. Munarriz, C. Santiago, M.J. Marques, J. Sanjuan, M. Gomez-Beneyto

    
  • ·DE03.01 Should-second generation antipsychotics be favored over traditional neuroleptics in the treatment of patients with schizophrenia?

    Page :292-293

    W.W. Fleischhacker

    Résumé Résumé Plan Plan

• Symposia

  • ·DE03.02 Contra

    Page :293-293

    L. Farde

    
  • ·SES15.01 A critical review in the work with severely traumatized

    Page :293-293

    M. Kastrup

    
  • ·SES15.02 Torture and the role of the physician — A historical and transcultural overview

    Page :293-293

    I. Sibitz, T. Wenzel

    
  • ·SES15.03 Treatment services for survivors of torture: A transcultural study

    Page :293-293

    T. Wenzel, A. Zoghlami, H. Griengl, W. Brause, I. Genefke

    
  • ·SES15.04 New approaches to the rehabilitation of torture victims in Hungary

    Page :293-293

    L. Hárdi, E. Kalamár

    
  • ·SES16.01 The future pattern of psychiatric provision in England

    Page :293-293

    D. Goldberg

    
  • ·SES16.02 Worrying indicators in schizophrenia treatment

    Page :293-293

    P. Munk-Jørgensen

    
  • ·SES16.03 Deinstitutionalization in Germany and Switzerland

    Page :294-294

    H.-J. Haug, W. Rössler

    
  • ·SES16.04 Deinstitutionalisation and psychiatric reform in Spain

    Page :294-294

    J.L. Vázquez-Barquero, J. Garcia

    
  • ·S39.01 Can better recognition and treatment of depression reduce suicide rates?

    Page :294-294

    Z. Rihmer

    
  • ·S39.02 Prevention of suicide and suicide attempt by adequate lithium long-term treatment

    Page :294-295

    B. Mueller-Oerlinghausen

    Résumé Résumé Plan Plan

• Symposia

  • ·S39.03 Clozapine and suicide prevention in schizophrenia

    Page :295-295

    M. Jakovljevi

    
  • ·S39.04 Prevention of suicides by long-term treatment with anti-depressants?

    Page :295-295

    J. Angst, F. Angst, H.H. Stassen, P.J. Clayton

    
  • ·S40.01 Psychiatry of extremal situation

    Page :295-295

    V.N. Krasnov

    
  • ·S40.02 Mental disorders in refugees

    Page :295-296

    Z.I. Kekelidze, D.P. Demonova

    Résumé Résumé Plan Plan

• Symposia

  • ·S40.03 Psychological defense and psychopathological disorders in victims of the Armenian earthquake of 1988

    Page :296-296

    M. Melik-Pashayan, K. Gasparyan

    
  • ·S40.04 Realistic evaluation of psychiatrical consequences of chernobyl accident

    Page :296-296

    V. Skavych

    
  • ·S41.01 A 2.5 year follow-up study of the efficiency of psychotherapeutic treatment of eating disorders

    Page :296-296

    J. Treasure, H. Kordy

    
  • ·S41.02 Motivation in eating disorders: Is it more than a fashion?

    Page :296-297

    U. Schmidt

    Résumé Résumé Plan Plan

• Symposia

  • ·S41.03 Diagnostic subgroups in eating disorders related to pain threshold

    Page :297-297

    H. Papežová, A. Yamamotová

    
  • ·S41.04 When the body speaks: The cultural context of eating disorders

    Page :297-297

    M. Katzman

    
  • ·S41.05 Guidelines for pharmacotherapy

    Page :297-297

    T. Bruna

    
  • ·C02.01 Interpersonal psychotherapy (IPT)

    Page :297-297

    E. Schramm

    
  • ·C06.01 Developing programmes against stigma and discrimination because of schizophrenia

    Page :297-298

    N. Sartorius, J.J. Lopez-Ibor, W. Gaebel, W. Schöny, G. Rossi

    Résumé Résumé Plan Plan

• Symposia

  • ·FC11.01 Phenomenology of schizophrenia in different gender

    Page :298-298

    M. Afzal Javed

    
  • ·FC11.02 The language of schizophrenia in XXth century: From phenomenological to illocutionary approach

    Page :298-298

    J. Zislin, V. Kuperman, R. Durst

    
  • ·FC11.03 Four-year stability of positive and negative schizotypal traits in normal adolescents from the general population

    Page :298-299

    N. Barrantes-Vidal, J.E. Obiols

    Résumé Résumé Plan Plan

• Symposia

  • ·FC11.04 A cluster analytic study of normal adolescents with neurodevelopmental neurocognitive, personality and social risk factors for schizophrenia spectrum disorders

    Page :299-299

    N. Barrantes-Vidal, A. Rosa, L. Fananas, J.E. Obiols

    
  • ·FC11.05 Hubin — human brain informatics: A clinical database project for multidisciplinary research in schizophrenia

    Page :299-299

    H. Hall, T. McNeil, S. Arnborg, I. Agartz, U. Ösby, J. Linder

    
  • ·FC11.06 A unified hypothesis of schizophrenia based on glutathione deficit

    Page :299-299

    M. Kirsten-Krüger, K.Q. Do, A.H. Trabesinger, C.J. Lauer, U. Dydak, D. Hell, F. Holsboer, P. Boesiger, M. Cuéod

    
  • ·SES17.01 Psychopathological phenotypes

    Page :300-300

    W.M.A. Verhoeven, S. Tuinier, L.M.G. Curfs

    
  • ·SES17.02 Behavioural phenotypes in different forms of X-linked mental retardation

    Page :300-300

    J.P. Fryns, M. Borghgraef, S. Frints, J. Steyaert, L.M.G. Curfs

    
  • ·SES17.03 Behavioural phenotypes in clinical practice

    Page :300-300

    L.M.G. Curfs, W.M.A. Verhoeven, S. Tuinier, J.P. Fryns

    
  • ·SES17.04 The behavioural phenotypes of genetic syndromes

    Page :300-300

    A.J. Holland

    
  • ·S42.01 Prodromal symptoms in schizophrenia: State of the art

    Page :300-301

    W. Gaebel, M. Jänner, N. Frommann

    Résumé Résumé Plan Plan

• Symposia

  • ·S42.02 Structural brain abnormalities in schizophrenia in relation to outcome

    Page :301-301

    W.G. Staal, H.E. Hulshoff Pol, H.G. Schnack, R.S. Kahn

    
  • ·S42.03 Test of serotonergic activity in the brain predicts therapeutic response of patients with schizophrenia

    Page :301-301

    J. Libiger, P. Mohr, J. Horáček, P. Czobor, R. Bahbouch

    
  • ·S42.04 Predicting long term recovery in schizophrenia: Findings from the International study of schizophrenia

    Page :301-301

    G. Harrison

    
  • ·S42.05 The predictability of adult individuals psychosocial characteristics on the basis of IQ and personality traits assessed in childhood

    Page :302-302

    L. Kubicka

    
  • ·S43.01 Social environment and suicidal behavior

    Page :302-302

    N. Okribelashvivi, S. Vashadze

    
  • ·S43.02 Epidemiological study of parasuicides in the city of Minsk in Belarus

    Page :302-302

    V. Poznyak, H. Ziborova, K. Rounets, L. Korolik, A. Popkov, P. Rynkov, E. Lasy, Z. Tereshkovitch

    
  • ·S43.03 Suicides in Lithuania

    Page :302-302

    R. Aranauskas

    
  • ·S44.01 Diagnosis and psychopathology: What defines a disorder?

    Page :302-303

    N.C. Andreasen

    Résumé Résumé Plan Plan

• Symposia

  • ·S44.02 Cultural framework of psychiatric diagnosis

    Page :303-303

    J.E. Mezzich

    
  • ·S44.03 Psychopathology and the WHO instruments for clinical assessment

    Page :303-303

    C.B. Pull, J.M. Cloos

    
  • ·S44.04 Patients express, psychiatrists interpret, what about the diagnostic categories? The issue of anxiety comorbid with depression in Turkey

    Page :303-303

    L. Küey

    
  • ·S44.05 Psychopathology, still the core of psychiatry

    Page :303-303

    P. Smolik

    
  • ·S45.01 Epidemiology of eating disorders

    Page :304-304

    H.W. Hoek, D. van Hoeken

    
  • ·S45.02 The course of eating disorders (AN, BN, BED): Predictors, risk factors and causal models

    Page :304-304

    M.M. Fichter, N. Quadflieg, J. Rehm

    
  • ·S45.03 Emotional model in eating disorders

    Page :304-304

    J. Treasure, N. Troop, A. Bond, T. Murphy, U. Schmidt

    
  • ·S45.04 Body image in eating disorders

    Page :304-304

    F. Fernández-Aranda

    
  • ·S45.05 Body image disturbances in obesity before and after weight loss

    Page :304-305

    M. Cuzzolaro, G. Vetrone, G. Marano

    Résumé Résumé Plan Plan

• Symposia

  • ·FC12.01 Risperidone for chronic schizophrenic patients on depot neuroleptics: A detailed clinical audit and switch study

    Page :305-305

    L. Conlon, J. Gilligan, T.J. Fahy

    
  • ·FC12.02 Could the schizotypal features explain the equivocal findings of the Wisconsin card sorting test in the first-degree relatives of patients with schizophrenia?

    Page :305-305

    A. Laurent, D. Bourdery, P. Séchier, T. Bougerol, T. D'Amato, J. Dalery

    
  • ·FC12.03 Recent dermatoglyphic studies in twin samples: Further evidences for an environmental risk factor in schizophrenia

    Page :305-306

    A. Rosa, L. Fañanás, A. Mcdonald, H.S. Bracha, B. Arias, E.F. Torrey, R.M. Murray, J. van Os

    Résumé Résumé Plan Plan

• Symposia

  • ·FC12.04 May P300 help differentiate the syndromatic patterns in schizophrenia?

    Page :306-306

    J. Maltez, N. Alves, J.P. Foreid, T. Pimentel, M. Abreu

    
  • ·FC12.05 Smoking in schizophrenia: Prevalence and associated features

    Page :306-306

    M. Gurpegui, M.C. Aguilar, J. de Leon

    
  • ·FC12.06 Alien voices: Does dysfunctional self-monitoring explain auditory hallucinations in schizophrenia?

    Page :306-307

    C.H.Y. Fu, M.J. Brammer, E. Amaro, S.C.R. Williams, N. Vythelingum, C. Andrew

    Résumé Résumé Plan Plan

• Symposia

  • ·SAT02.01 Making remission an achievable goal — specialist's utopia versus generalist's reality?

    Page :307-307

    A. Wade

    
  • ·SAT02.02 Optimising long-term treatment of depression

    Page :307-307

    Y. Lecrubier

    
  • ·SAT02.03 Quality of life issues in long-term treatment with antidepressants

    Page :307-307

    P. Bech

    
  • ·SAT02.04 Maintaining response to antidepressants

    Page :307-307

    M. Lader

    
  • ·S46.01 Consultation-liaison psychiatry, primary and secondary care

    Page :307-307

    A. Lobo

    
  • ·S46.02 Quality management, accreditation and certification processes in C-L psychiatry

    Page :307-308

    M. Rigatelli, B. Bertoncelli

    Résumé Résumé Plan Plan

• Symposia

  • ·S46.03 Consultation-liaison psychiatry in Europe: Current issues — The importance of cost-effectiveness studies

    Page :308-308

    F. Creed

    
  • ·S46.04 Consultation-liaison psychiatry and psychosomatics: Quality management and guideline development — A European perspective

    Page :308-308

    T. Herzog

    
  • ·S47.01 Abulia following brain injury

    Page :308-308

    K. Barrett

    
  • ·S47.02 Treatment of affective disorders after brain injury

    Page :308-308

    P. Eames

    
  • ·S47.03 Pharmacotherapy of neuropsychiatric disorders following brain injury

    Page :308-309

    U. Müller

    Résumé Résumé Plan Plan

• Symposia

  • ·S47.04 Psychopathology following brain injury; Impact on return to work

    Page :309-309

    P. North

    
  • ·S48.01 Quality in accreditation to the excellence

    Page :309-309

    G.V. Rossi, A. Erlicher, C. Barbini, A. Righi

    
  • ·S48.02 How to state procedures in mental health: The genoa department of mental health experience

    Page :309-309

    L. Ferrannini, G. Boidi, P. Ciancaglini

    
  • ·S48.03 Ideologies and accreditations

    Page :309-309

    F.A. Jenner

    
  • ·S48.04 Standardised description of psychiatric care. The need to place every service in its specific context

    Page :309-309

    G. Tibaldi, C. Munizza

    
  • ·S49.01 Atypical antipsychotics in schizoaffective disorders

    Page :309-309

    S. Montgomery

    
  • ·S49.02 Atypical antipsychotics in bipolar disorder

    Page :309-309

    
  • ·S49.03 Atypical antipsychotics in resistant depression, delusion depression

    Page :310-310

    S. Kasper

    
  • ·S49.04 Impact of neurotic symptoms on the response to 4 years treatment with clozapine in drug resistant psychotic patients

    Page :310-310

    G.B. Cassano, A. Ciapparelli

    
  • ·S49.05 Atypical antipsychotics in neurology (Parkinson, tourette, dementia, etc)

    Page :310-310

    
  • ·S50.01 Assessment of disablement in schizophrenia

    Page :310-310

    H.W. Hoek, K. van Hoof, D. van Hoeken, M. van der Gaag

    
  • ·S50.02 The influence of personality on the assessment of disablement

    Page :310-310

    N. Glozier

    
  • ·S50.03 Disability in mental and physical patients

    Page :310-310

    J.L. Vázquez-Barquero, S. Herrera Castanedo, M.E. Vázquez Bourgon, L. Cardenal, A. Gómez, M. Uriarte

    
  • ·S50.04 Disability and disability assessment in anxiety disorders

    Page :310-310

    C.B. Pull, J.M. Cloos, P. Straus, A. Sztantics, M.C. Pull

    
  • ·S51.01 The odin project: Study design and instruments

    Page :311-311

    J.L. Ayuso-Mateos, J.L. Vazquez-Barquero

    
  • ·S51.02 Urban-rural differences in the prevalence of depression in Europe: Evidence from the odin project

    Page :311-311

    V. Lehtinen, E. Michalak, C. Wilkinson, C. Dowrick, J.L. AyusoMateos, O.S. Dalgard, P. Casey, J.L. Vazquez-Barquero, G. ilkinson

    
  • ·S51.03 Negative life events, social support and depression in the odin study

    Page :311-311

    O.S. Dalgard

    
  • ·S51.04 Personality factors in depressive disorders

    Page :311-311

    A. Horgan, P. Casey

    
  • ·S51.05 Trial of psychological intervention in the community

    Page :311-311

    C. Dowrick

    
  • ·W05.01 Mental health care in Hungary

    Page :311-311

    I. Bitter

    
  • ·W05.02 Current trends in czech psychiatry

    Page :311-311

    J. Raboch, P. Baudiš

    
  • ·W05.03 Future perspectives of Swiss psychiatry

    Page :311-311

    W. Rössler

    
  • ·W05.04 Follow-up of changes of psychiatric care (intra- and extramural)

    Page :312-312

    G. Hofmann

    
  • ·WPA.01 The use of the WPA/PTD educational programme on the recognition and treatment of depressive disorders

    Page :312-312

    N. Stefanis, J.E. Cooper, N. Kornetov

    
  • ·FC13.01 Severe mental illness and airports — The scope of the problem

    Page :312-312

    B.B. Lucas, U.C. Wieshmann, M. Anjoyeb

    
  • ·FC13.02 Utilisation of emergency departments by substance abusers: Drug-related problems in a multicentric epidemiological study in France

    Page :312-313

    P. Nuss, M. Ferreril, P. Espinoza, F. Mathyz

    Résumé Résumé Plan Plan
  • ·FC13.03 The recognition of common mental disorder by non-psychiatric physicians in Taiwan

    Page :313-313

    S.-I. Liu, A. Mann

    
  • ·FC13.04 Unplanned discharge in a psychiatric day clinic — Trying to differentiate the reasons

    Page :313-313

    P. Garlipp, K.-P. Seidler, K. Amini, W. Machleidt, H. Haltenhof

    
  • ·FC13.05 Predicting admissions in emergency psychiatry

    Page :313-313

    C.L. Mulder, P.C.A. van der Graafi, P. de Jonge, A.A. de Groot, J.S. Lyons

    
  • ·FC13.06 The cross-national epidemiology of unexplained chronic fatigue

    Page :313-314

    P. Skapinakis, G. Lewis, V. Mavreas

    Résumé Résumé Plan Plan
  • ·PS04.01 Pharmacological treatment of schizophrenia

    Page :314-314

    W.W. Fleischhacker

    
  • ·PS04.02 Psychosocial treatment

    Page :314-314

    J. Left

    
  • ·PS04.03 Rehabilitation

    Page :314-314

    W. Rossler

    
  • ·S52.01 Cerebral MRI findings in schizophrenia: A review of the evidence

    Page :315-315

    A. Vita, M. Dieu, L. Delen, F. Tenconi

    
  • ·S52.02 Structural changes in first-episode schizophrenia

    Page :315-315

    E. Ceskova, B. Prokes, M. Lorenc, P. Drybcak, M. Ondrusova

    
  • ·S52.03 Pet studies of cognition and emotion in schizophrenia

    Page :315-315

    N.C. Andreasen

    
  • ·S52.04 Functional spect findings in schizophrenia

    Page :315-315

    S. Kasper

    
  • ·S52.05 The role of rCBF (99Tc HMPAO) measurements in the assessment of a psychiatric patient

    Page :315-315

    J. Libiger, M. Kopecek, A. Urban, K. Kupka

    
  • ·S53.01 Prodromes of relapse and first episode of psychoses: Different or same?

    Page :316-316

    M. Birchwood

    
  • ·S53.02 Cognitive and behavioral functioning during the decade prior to first hospitalization and during early course of schizophrenic illness

    Page :316-316

    M. Davidson

    
  • ·S53.03 Vulnerability markers and prediction of imminent psychosis

    Page :316-316

    P. Jones

    
  • ·S53.04 The cologne early recognition project

    Page :316-316

    J. Klosterkotter

    
  • ·S53.05 Screening and describing subjects with prodromals to schizophrenia

    Page :316-316

    R.K.R. Salokangas, M. Heinimaal, T. Ilonen, T. Suomelal, M. Korkeilal, M. Plathin, T. Ristkaril, J. Huttunen, J. Hietala, E. Syvilahti, T.H. McGlashan

    
  • ·SES18.01 Personality dimensions in affective disorders

    Page :316-316

    P. Pichot

    
  • ·SES18.02 The ICS-10 personality disorders relevant for affective disorders

    Page :316-316

    C. Pull

    
  • ·SES18.03 Bipolar personality dimensions and the choice of mood stabilizers in long-term treatment

    Page :317-317

    H.S. Akiskal

    
  • ·SES18.04 Personality dimensions as predictors of treatment outcome in affective disorders

    Page :317-317

    P. Tyrer, H. Seivewright, T. Johnson

    
  • ·SES18.05 Treatment of social phobia: The association of personality and affective symptoms

    Page :317-317

    P. Bech

    
  • ·S54.01 The pathopysiology of formal thought disorder

    Page :317-317

    T.T.J. Kircher, P.F. Liddle, M. Brammer, S.C.R. Williams, R.M. Murray, P.K. McGuire

    
  • ·S54.02 Using pet to study dopamine release in vivo

    Page :317-318

    P.M. Grasby, C. Bench, M. Knepp, R. Gunn, C. Messa

    Résumé Résumé Plan Plan
  • ·S54.03 Functional anatomy of auditory hallucinations

    Page :318-318

    P.K. McGuire

    
  • ·S54.04 A system model of altered consciousness: Integrating natural and drug-induced psychoses

    Page :318-318

    F.X. Vollenweiderl, K.L. Leenders, Ch. Scharfetterl, D. Hell

    
  • ·S55.01 Depression in Tunisia: Another gender inequality?

    Page :318-318

    S. Douki

    
  • ·S55.02 Postpartum depression: A prospective study

    Page :318-318

    D. Moussaoui

    
  • ·S55.03 PMS/PMDD: Diagnosis and treatment

    Page :318-318

    M. Steiner

    
  • ·S55.04 Premenstrual in the general population: An epidemiological study

    Page :318-318

    N. Kadiri

    
  • ·W15.01 When physicians commit suicide: Reflections of those they leave behind (videotape)

    Page :319-319

    M.F. Myers

    
  • ·FC14.01 The predictability of adult individuals' psychosocial characteristics on the basis of IQ and personality traits assessed in childhood

    Page :319-319

    L. Kubicka, Z. Dytrych, Z. Matejcek, Z. Roth

    
  • ·FC14.02 Child psychiatric disorders — A community sample

    Page :319-319

    V. Eapen, M.E. Jakkal, M.T. Abou-Saleh

    
  • ·FC14.03 Assertive community treatment: Ethical and legal dilemmas

    Page :319-319

    J. Stovall

    
  • ·FC14.04 The defence mechanism test in panic disorder, generalized anxiety disorder and schizophrenia

    Page :319-320

    L. Bogren, I.-B. Bogren

    Résumé Résumé Plan Plan
  • ·FC14.05 Anxiety and personality correlates in patient with somatoform disorder

    Page :320-320

    C. Pruneril, E. Pellegrini, S. Damiano, F. Furlani

    
  • ·FC14.06 Personality tests assesment in a selected cohort of french applicants for sex reassignement linked to the problem of sexual identity

    Page :320-320

    T. Gallarda, S. Coussinoux, B. Cordier, M. Haddou, I. Amado, M.F. Poirier, M.C. Bourdel, J.P. Olie

    
  • ·P01.01 The somatic etiology of cycloid psychoses

    Page :321-321

    E. Franzek

    
  • ·P01.02 Light therapy for treatment indications other than seasonal affective disorder

    Page :321-321

    A. Neumeister, A. Graf, M. Willeit, S. Kasper

    
  • ·P01.03 The correlation between work psychopatology and migration

    Page :321-321

    M. Mattia

    
  • ·P01.04 Training of future psychiatrists for psychotherapeutic work with psychotic patients

    Page :321-321

    M. Patris, Ph. Amarilli

    
  • ·P01.05 Clinical validity of ICD-l0 neurasthenia

    Page :322-322

    B. Bankier, M. Aigner, A. Spacek, S. Krones, M. Bach

    
  • ·P01.06 Alexithymia in DSM-IV disorder: Comparative evaluation in somatoform disorders, panic disorder, obsessive-compulsive disorder, and depression

    Page :322-322

    B. Bankier, M. Aigner, U. Demal, M. Bach

    
  • ·P01.07 Rem-sleep behavior disorder in the elderly

    Page :322-322

    H. Chiu, L. Lam

    
  • ·P01.08 Depressive mixed state in atypical depression

    Page :322-322

    F. Benazzi

    
  • ·P01.09 The intellectual development, mental and behavioral disorders in the children from belarus exposed in utero following the chernobyl accident

    Page :323-323

    S. Igumnov, V. Drozdovitchl

    
  • ·P01.10 Elderly men loneliness: Contribution into development of psychological and sexual isolation

    Page :323-323

    M. Yagoubov

    
  • ·P01.11 Distribution and drinking patterns in seamen in the European North of Russia

    Page :323-323

    A.G. Kalinin, P.I. Sidorov, O. Nilssen, T. Brenn

    
  • ·P01.12 Ethic decisions on involuntary treatment of patients with schizophrenia

    Page :323-324

    T. Steinert, D. Herforth, R.P Gebhardt

    Résumé Résumé Plan Plan
  • ·P01.13 Clinical and eeg predictors of the therapepeutic outcome of electroconvulsive therapy

    Page :324-324

    M. Hrdlicka, M. Blatny, M. Moran, J. Vachutka, J. Rozinkova

    
  • ·P01.14 Olanzapine: Effects on neuropsychological test performances in the schizophrenic spectrum

    Page :324-324

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    
  • ·P01.15 Neurocognitive changes in adjustment disorder with depressed mood: Use of paroxetine

    Page :324-324

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    
  • ·P01.16 Gabapentin in antipsychotic-induced movements

    Page :324-325

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    Résumé Résumé Plan Plan
  • ·P01.17 Adjunctive amisulpride to fluvoxamine in major depression: Early ssri onset of action

    Page :325-325

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    
  • ·P01.18 Role of pro-inflammatory cytokines in down's syndrome

    Page :325-325

    M.G. Carta, M.C. Hardoy, P.E. Manconil, P. Serra, A. Barrancal, C.M. Caffarelli, E. Mancal, A. Ghianil

    
  • ·P01.19 Lack of effects of st john's wort extract on autonomic and cognitive functions

    Page :325-325

    M. Siepmann, M. Muck-Weymann, P. Joraschkyl, W. Kirch

    
  • ·P01.20 Comparison of effects of panic disorder with agoraphobia in men and women

    Page :326-326

    M. Latast, V. Starcevicz, A. jordjevic

    
  • ·P01.21 Augmantation with d2 antagonists for partial reponders to atypical antipsychotics

    Page :326-326

    D. Mazeh, Y. Melamed, A. Elizur

    
  • ·P01.22 Predictors of chronicity and health service use in patients presenting unexplained physical symptoms

    Page :326-326

    R.E. Taylor, D.P Goldberg, A.H. Mann

    
  • ·P01.23 Compliance inventory (CI-6)

    Page :326-326

    R.-P. Gebhardt, T. Steinert, M. Wölfle

    
  • ·P01.24 Proximity to the community or specialisation of psychiatric in-patient care (part 1)

    Page :327-327

    R.-P Gebhardt, M. Wolfle, P.-O. Schmidt-Michel

    
  • ·P01.25 The motivations for opiate use among addicts of shiraz self-identified center

    Page :327-327

    A. Ghanizade, J. Ahmadi

    
  • ·P01.26 The effect of cultural factors on students' drug use

    Page :327-327

    A. Ghanizadeh

    
  • ·P01.27 A comparison of two different instruments assessing the individual need for care

    Page :327-328

    G. Spinner, R.P. Gebhardt

    Résumé Résumé Plan Plan
  • ·P01.28 Effects of new antipsychotics on serum prolactin and testosterone level in schizophrenic patients

    Page :328-328

    D. Han, D. Park, C. Na

    
  • ·P01.29 Psychiatry in intelectual disability: The tools of care” in Geneva

    Page :328-328

    M.F. Kummer, G. Carminati

    
  • ·P01.30 Altered biochemical bone remodelling markers in schizophrenia

    Page :328-328

    A. Herran, M.T. Garcia-Unzueta, J.A. Amado, J. GonzalezMacias, L. Perera, J.L. Vázquez-Barquero

    
  • ·P01.31 Functional relationship between enzymes MAOA and ace in human brain?

    Page :328-329

    O. Šerý, V. Znojil, V. Mikeš, P. Zvolsky

    Résumé Résumé Plan Plan
  • ·P01.32 Social factors and women's mental health in Russia

    Page :329-329

    T. Dmitrieva, M. Kachaeva

    
  • ·P01.33 Event related potentials and neuropsychological tests in obsessive-compulsive disorder

    Page :329-329

    B.B. Kivircik, G.G. Yener, K. Alptekin, O.C. Eigin, H. Aydin

    
  • ·P01.34 Disability pension among psychiatric outpatients with major depression

    Page :329-329

    M. Sorvaniemi, H. Helenius, R.K.R. Salokangas

    
  • ·P01.35 Aggresion in mild retarded people as family problem reflection

    Page :329-330

    S. Betskov, E. Krivulin

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.40 Efficacy of venlafaxine in depressed patients after switching from prior SSRI treatment

    Page :331-331

    C. Reynaert, P. Janne, N. Zdanowics, A. Mignon

    
  • ·P01.41 Efficacy of venlafaxine in depressed patients after failure with prior antidepressant treatment

    Page :331-331

    M. De Clercq, A. Mignon

    
  • ·P01.42 Symptom relief obtained with venlafaxine versus fluoxetine in depressed patients with concomitant anxiety

    Page :331-331

    A. De Nayer, M. De Clercq, A. Mignon

    
  • ·P01.43 Dopamine transporter genotypes and imaging in tourette disorder

    Page :332-332

    P. Schüssler, M. Stamenkovic, S.-D. Schindler, S. Asenbaum, K. Fuchs, F. Leisch, F. Riederer, W. Sieghart, S. Kasper, K. Hornik, H.N. Aschauer

    
  • ·P01.44 Obsessional-compulsive symptoms in four groups of eating disorders screened by SCL-90

    Page :332-332

    M. Campana, P. Colleoni, P. Drago, M. Nava, M. Riglietta, L. Tidone

    
  • ·P01.45 Evaluation of psychiatric co-morbidity in a group of binge eating disorders screened by SCL-90

    Page :332-332

    M. Carnpana, P. Colleoni, P. Drago, M. Nava, M. Riglietta, L. Tidone

    
  • ·P01.46 Prevalence and severity of psychiatric co-morbidity in different addictive disorders

    Page :333-333

    M. Riglietta, M. Campana, P. Drago, M. Fusini, L. Tidone

    
  • ·P01.47 The European long and short term amisulpride (ELSA) study. AN international comparative study on the utilisation of amisulpride in routine care

    Page :333-333

    M. Linden, G. Agnes

    
  • ·P01.48 Dimensions of psychopathology in schizophrenia: A factor analysis of the amisulpride database

    Page :333-333

    W. Rein

    
  • ·P01.49 Low dose amisulpride: Some evidence for alertness-increasing properties in EEG studies

    Page :334-334

    E. Legangneux, P. Rosenzweig, B. Saletu, H. Allain

    
  • ·P01.50 Alcoholics life quality evaluation

    Page :334-334

    P.I. Sidorov, A.G. Soloviev

    
  • ·P01.51 Medical follow-up of attempters in the year preceding suicide

    Page :334-334

    F. Chastang, L. Leclerc, P. Rioux, V. Kovess, E. Zarifian

    
  • ·P01.52 The efficacy and safety of risperidon in children with autistic disorder

    Page :334-334

    R.S. Dýler, S. Firat, A. Avcil

    
  • ·P01.53 Psychotherapy in the correction of sexual disharmony

    Page :335-335

    M.V Markova

    
  • ·P01.54 Posttraumatic stress disorders (PTSD) in Ukraine

    Page :335-335

    B.V Mykhaylov, V.G. Cherkasov, U.N. Astapov

    
  • ·P01.55 Agression and strategic problems of psychiatry in Ukraine

    Page :335-335

    A.I. Serdyuk, B.V Mykhaylov

    
  • ·P01.56 Gamma-hydroxy buthyric acid (alcover) in the treatment of alcohol withdrawal syndrome

    Page :335-335

    L. Kovács, G. Kovács

    
  • ·P01.57 The cultural context of psychostimulant use

    Page :335-336

    Zs. Demetrovics

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.58 Lack of effect of vitamin B₆ on psychotic symptoms in chronic schizophrenic and schizoaffective patients: a double-blind placebo-controlled study

    Page :336-336

    V. Lerner, C. Miodownik, A. Kaptsan, H. Cohen, M. Matar, U. Lowenthal, M. Kotler

    
  • ·P01.59 Is prescription of cyamemazine useful to favor withdrawal of benzodiazepines after long term treatment?

    Page :336-336

    P. Lemoine, F. d'Alché-Birée, S. Garcia-Acosta, M. Dib

    
  • ·P01.60 What's beneath the skin?

    Page :336-336

    M. Moretti, T. Kurimay

    
  • ·P01.61 Study of conversion factor between zuclopenthixol (ZCP) acetate and ZCP decanoate in patients receiving high doses of ZCP acetate

    Page :336-337

    F.R. Cousin, C. Gury

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.62 Efficacy of venlafaxine er in gad patients with predominantly somatic symptomatology

    Page :337-337

    D. Hackett, J. Rasmussen, P. Meoni

    
  • ·P01.63 Venlafaxine er action on generalized anxiety disorder (GAD)-specific anxiety symptoms

    Page :337-337

    P. Meoni, D. Hackett, Y. Brault, E.O. Salinas

    
  • ·P01.64 Quality of response in GAD: is response to placebo the same as response to active treatment?

    Page :337-337

    P. Meoni, D. Hackett, C. White

    
  • ·P01.65 Beliefs about depression and outcome in major depression: A pilot study

    Page :338-338

    P.L. Cornwall, B.R. Pollinger, M. Pope

    
  • ·P01.66 Case report: Sexual offending in a man with aspergers syndrome, XYY syndrome and a seizure disorder

    Page :338-338

    K.P Courtenay, J. Bird

    
  • ·P01.67 Case report: Prader-willi syndrome and bipolar affective disorder with psychosis

    Page :338-338

    K.P. Courtenay, L. Magrill

    
  • ·P01.68 Current and residual functional disability associated with psychopathology. Findings from the Netherlands mental health survey and incidence study (NEMESIS)

    Page :338-338

    R.V. Bijl

    
  • ·P01.69 Multiple sclerosis and eating disorders

    Page :338-339

    D. Kountouris

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.70 Oxcarbazepine as a mood regulator: Its efficacy, safety and tolerability versus carbamazepine

    Page :339-339

    G. Tavormina

    
  • ·P01.71 Help-seeking behaviour and coping preceding first psychiatric admission of psychosis patients

    Page :339-339

    J. Fuchs, T. Steinert

    
  • ·P01.72 Psychosocial status of female transsexuals after surgical sex reassignment

    Page :339-339

    L. Vasilenko, L. Gorobetz

    
  • ·P01.73 Socio-invironmental factors and neurotic disorders among children

    Page :340-340

    N.K. Suchotina

    
  • ·P01.74 Loneliness states and associated with them disorders of depressive spectrum beside persons of late age

    Page :340-340

    J. Polichtchouk, L. Golubtsova, V. Gurvich, A. Kolpakov

    
  • ·P01.75 Correlation of the anticonvulsant using in psychiatric clinic of the epileptology center

    Page :340-340

    E. Maxoutova, E. Jeleznova, L. Sokolova, A. Zemlyanaya

    
  • ·P01.76 Use of dalargin in the treatment of compulsive craving in opiate addiction

    Page :340-340

    S. Matevosyan, A. Belkin

    
  • ·P01.77 Multifactorial psychological study of somatoform disorders

    Page :341-341

    A. Kholmogorova, N. Garanian, P. Sheib, M. Wiersching

    
  • ·P01.78 Familial context of somatoform disorders

    Page :341-341

    A. Kholmogorova, S. Volikova

    
  • ·P01.79 Social consequences of heroin addiction

    Page :341-341

    L.A. Tchistyakova

    
  • ·P01.80 Industrial rehabilitation and psychological protection

    Page :341-341

    P. Pyrkov

    
  • ·P01.81 Clinical features of female heroin addiction

    Page :341-342

    S.O. Mokhnatchev

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.82 Dependence of medical and social consequences of drug addiction on predisposing factors

    Page :342-342

    A.A. Kozlov

    
  • ·P01.83 Degrees of mental disorder in vasqulocerebral pathology

    Page :342-342

    G. Kindras, L. Borisova, R. Kondratenko, D. Ogar

    
  • ·P01.84 Neurofibromatosis type 1: Neuropsychology and MRI correlates

    Page :342-342

    R. Feldmann, M. Oelerich, T. Allkemper, U. Wiegard, M. Pietsch, J. Weglage

    
  • ·P01.85 Addictions: Situation in belarus by 2000

    Page :343-343

    O. Liskovski

    
  • ·P01.86 Preliminary results from the international personality disorders examination (IPDE) field trial in Greece

    Page :343-343

    K.N. Fountoulakis, A. Iacovides, C. loannidou, F. Bassala, G. Kaprinis

    
  • ·P01.87 Dexamethasone suppression test, personality disorders and stressful life events in clinical subtypes of major depression

    Page :343-343

    K.N. Fountoulakis, A. lacovides, F. Fotiou, M. Karamouzis, A. Demetriadou, G. Kaprinis

    
  • ·P01.88 Attempted suicide by hanging in young children

    Page :343-343

    S.M. Stein, N. Chalhoub, C. Masterson

    
  • ·P01.89 Applying the work of wilfred bion to the treatment of psychotic adolescents

    Page :344-344

    S.M. Stein

    
  • ·P01.90 Effects of clozapine on autonomic functions: Non-invasive biomonitoring from the skin

    Page :344-344

    M. Mueck-Weymann, J. Acker, T. Rechlin, P. Joraschky

    
  • ·P01.91 Behavioural genetics of cognitive disturbances in schizophrenia

    Page :344-344

    M.V. Alfimova, L.G. Uvarova, V.I. Trubnikov

    
  • ·P01.92 Multicenter double bind randomized oarralkel-group clinical trial of effectiveness of the combinaion clomipramine plus lithium carbonate versus clomipramine plus placebo in the treatment of unipolar depression

    Page :344-345

    D. Januel, M.-F. Poirier, F. D'Alche-Biree, M. Dib, J.-P. Olie

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.93 The networking model in the prevention of child abuse and neglect

    Page :345-345

    M. Pejovic Milovancevic, O. Vidojevic, V. Ispanovic Radojkovic, T. Mincic

    
  • ·P01.94 First episode of schizophrenia — Efifcacy of olanzapine as first choice neuroleptic

    Page :345-345

    D. Prelipceanu, R. Mihailescu, C. Andreescu

    
  • ·P01.95 Psychosocial correlates of endocrine disease: The integration of different criteria

    Page :345-345

    N. Sonino, C. Ruini, F. Ottolini, C. Navarrini, G.A. Fava

    
  • ·P01.96 Quality of life profile in patients with suicidal activity (ideation or attempt)

    Page :345-346

    C. Fenández, P.A. Sáiz, J.C. González, M.P. González, Y. Ramos, M. Bousoño

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.97 Health status and elderly people

    Page :346-346

    P.A. Sáiz, Ma.P. Gonzilez, J.Ma. Fernindez, S. Martinez, Ma.T. Bascarán, J. Bobes

    
  • ·P01.98 Apolipoprotein e genotype and schizophrenia

    Page :346-346

    P.A. Sáiz, M. Gonzilez-Quiros, V. Alvárez, E. Coto, J.Ma. Fernández, M. Bousoño

    
  • ·P01.99 Suicidal behaviour and the tryptophan hidroxylase and the apolipoprotein E genes polymorphisms

    Page :346-346

    P.A. Sáiz, B. Morales, M. Gonzilez-Quiros, V. Alvárez, E. Coto, J.Ma. Fernández, M. Bousoño

    
  • ·P01.100 Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with alzheimer's dementia

    Page :346-347

    J.S. Street, W.S. Clark, B.E. Juliar, P.D. Feldman, D.L. Kadam, A. Breier

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.101 Possible mechanisms for the efficacy of olanzapine in preventing relapse in schizophrenia

    Page :347-347

    B. Jones, C.C. Taylor

    
  • ·P01.102 Olanzapine in the prevention of psychosis among nursing home patients with behavioral disturbances associated with Azheimer's disease

    Page :347-347

    W.S. Clark, J.S. Street, T.M. Sanger, P.D. Feldman, A. Breier

    
  • ·P01.103 Activity assessments of superoxide dismutase, glutathione reductase and glutathione peroxidase in the red blood cells of Alzheimer patient's

    Page :347-347

    J. Leszek, A. Kiejna, B. Janicka, E. Trypka, R. Górna

    
  • ·P01.104 Relation of suicidal behaviour, central serotonergic system and temperament and character inventory

    Page :347-348

    U. Itzlinger, A. Heiden, J. Scharfetter, C. Gebhardt, P. Schüssler, K. Fuchs, W. Sieghart, S. Kasper, H. Aschauer

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.105 Alpha-1-acid glycoprotein and suicidality in major depressive disorder

    Page :348-348

    E. Nieto, E. Vieta, L. Alvarez, M. Torra, C. Gastó

    
  • ·P01.106 Erectile dysfunction secondary to partners vagwismus: Cultural perspective: Case reports

    Page :348-348

    M.L. Soylul, S. Uguz

    
  • ·P01.107 Proximity to the community or specialisation of psychiatric in-patient care (Part 2)

    Page :348-348

    M. Wℓfle, R.-P. Gebhardt, P.-O. Schmidt-Michel

    
  • ·P01.108 Changes of quality of life of hiv/aids patients in comparison with a control group

    Page :348-349

    J. Potribnál, E. Dragomirecká

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.109 Psychological mechanisms of sexual homicide behavior

    Page :349-349

    N. Dvorianchikov, A. Gerasimov

    
  • ·P01.110 Psychoeducation and relapse of schizophrenia

    Page :349-349

    L. Motlova, F. Spaniel, I. Vaňurová, J. Klaschkal

    
  • ·P01.111 The quality of life in panic disorder

    Page :349-350

    P. Delia-Marina

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.112 Audible thinking: A specific trait marker for schizophrenia?

    Page :350-350

    S. Lafont-Rapnouil, B. Laffy-Beaufils

    
  • ·P01.113 Inpatient service utilisation in first episode psychosis: Patterns and predictors during the first three years

    Page :350-350

    A. Sipos, G. Harrison, D. Gunnell

    
  • ·P01.114 Mental health and modern armed conflict in the chechen republic

    Page :350-350

    E. Koren

    
  • ·P01.115 Temperament and character traits in women with suicidal attempt

    Page :351-351

    T. Zujovic, B. Miljanovic, V. Tepsic

    
  • ·P01.116 Serotonin transporter and serotonin receptor genes polymorphisms in the Russian patients with schizophrenia and affective disorders

    Page :351-351

    V. Golimbet, T. Sherbatich, K. Manandyan, L. Abramova, V. Orlova, V. Kaleda, I. Oleichik, V. Bondar, Yu. Yurov, V. Trubnikov, E. Rogaev

    
  • ·P01.117 Contingent negative variation in depression: Relationship with personality

    Page :351-351

    M. Hansenne, W. Pitchot, E. Pinto, J. Reggers, M. Ansseau

    
  • ·P01.118 Event-related potential and personality in depression

    Page :351-351

    M. Hansenne, W. Pitchot, E. Pinto, J. Reggers, M. Ansseau

    
  • ·P01.119 Implication of 5HT1A receptors in male alcoholic patients

    Page :352-352

    E. Pinto, J. Reggers, W. Pitchot, M. Hansenne, S. Fuchs, M. Ansseau

    
  • ·P01.120 Electroconvulsive therapy in patients with silent cerebral infarction and major depression

    Page :352-352

    T. Zujovic, V. Tepsic, J. Antonijevic, M. Blagojevic

    
  • ·P01.121 Late-onset agranulocytosis during clozapine treatment: A case report

    Page :352-352

    L. Tamam, E. Kulan, N. Ozpoyraz

    
  • ·P01.122 Personality disorders in patients with bipolar-1 disorder

    Page :352-353

    L. Tamam, E. Kulan, N. Ozpoyraz

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.123 Comorbidity of anxiety disorders in patient with bipolar-I disorder

    Page :353-353

    L. Tamam, N. Ozpoyraz

    
  • ·P01.124 Depressive episode treatment with citalopram in patients with human immunodeficiency virus (HIV) infection: A double blind clinical study

    Page :353-353

    R. Vazquez-Noguerol, M. Alvarez, A. Perez-Bravo, J. Olivares

    
  • ·P01.125 Metachromatic leukodystrophy vs. schizophrenia: A case report

    Page :353-353

    E.G. de Miguel, J.V. Guerrero

    
  • ·P01.126 Subthreshold psychiatric disorders influence the subjective well-being of the elderly

    Page :353-353

    A. Papassotiropoulos, R. Heun

    
  • ·P01.127 Event related potentials (CNV and P300) in chronic opiate users: Preliminary results

    Page :354-354

    E. Pinto, J. Reggers, W. Pitchot, M. Hansenne, S. Fuchs, J.-J. Legros

    
  • ·P01.128 Reduced dopaminergic activity in depressed suicides

    Page :354-354

    W. Pitchot, J. Reggers, E. Pinto, M. Hansenne, S. Fuchs, M. Ansseau

    
  • ·P01.129 Three syndromes of schizophrenia — Results of an EFA - CFA - crossvalidation approach

    Page :354-354

    R.T. Schaub, R.-D. Stieglitz

    
  • ·P01.130 Alterations of gait in healthy controls compared to depressed patients treated with TCA and SSRI

    Page :354-355

    M.R. Lemke, T. Wendorff

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.131 Treatment of depression in Parkinson's disease with reboxetine

    Page :355-355

    M.R. Lemke

    
  • ·P01.132 Safety during long-term exposure to Seroquel® (quetiapine)

    Page :355-355

    A.P. Gorman, E.K. Westhead

    
  • ·P01.133 Efficacy of ‘Seroquel’ (quetiapine) compared with haloperidol and placebo in the short-term treatment of acute schizophrenia

    Page :355-355

    S.C. Schultz, A.M. Jones

    
  • ·P01.134 Plasma leptin in patients with eating disorders

    Page :356-356

    A. Tortorella, P. Monteleone, R. Ioime, V. Martiadis, M. Maj

    
  • ·P01.135 Cross-cultural aspect of alcohol use and misuse

    Page :356-356

    Y.E. Razvodovsky

    
  • ·P01.136 Relationship of schizotypal dimensions and hypomanic traits with creative thinking in normal subjects

    Page :356-356

    N. Barrantes-Vidal, J.E. Obiols

    
  • ·P01.136 Neurological abnormalities in African-Caribbean and white British first-episode psychosis patients

    Page :356-357

    F. Fonseca, P. Dazzan, K.G.D. Orr, G. Hutchinson, K.D. Morgan, J. Salvo, S. Verneals, M. Sharpley, C. Morgan, J. McCabe, B. Chapple, R. Mallett, J. Leff, R.M. Murray

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.138 The influence of familial loading on the course of schizophrenic symptoms and the success of psychoeducational therapy

    Page :357-357

    R. Feldmann, W.P. Hornung, G. Buchkremer, V. Arolt

    
  • ·P01.139 Treatment of sick doctors. The experience of a specialized unit

    Page :357-357

    A. Gual

    
  • ·P01.140 Comparison of depressive disorders in years 1990 and 1999

    Page :357-357

    E. Panagoulias, K. Dailianis, P. Papadopoulos, G. Tychopoulos

    
  • ·P01.141 Adherence to antiretroviral therapy among patients in a methadone maintenance program

    Page :357-358

    G. Perez, M. Torrens, R. Martin-Santos, C. Castillo, J. Sangorrin, M. Cabre

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.142 EEG of relatives of schizophrenics: Peculiarities and associations with cognitive and CT parameters

    Page :358-358

    L. Uvarova, V. Golimbet, M. Alfimova, N. Savvateeva, Y. Yurov, V. Trubnikov

    
  • ·P01.143 Characteristics of patients registered in databases of the clozapine monitoring system in Slovakia

    Page :358-358

    J. Pecenak, V. Novotny

    
  • ·P01.144 Distribution of serotonin transporter gene variants in human populations: A possible tool for understanding some aspects in psychiatric epidemiology

    Page :358-358

    S. Papiol, B. Gutiérrez, B. Arias, A. Rosa, B. Matín, L. Fañanás

    
  • ·P01.145 Amyloid beta peptide 1–40 influences a recognition site of hemicholinium-3 sensitive choline carriers and their proteolytic degradation

    Page :358-359

    Z. Krištofiková, H. Tejkalová

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.146 Interrater reliability of the clinical global impressions (CGI) scale in schizophrenia and depression: Results from a chart review reliability study

    Page :359-359

    M.J. Müller

    
  • ·P01.147 Analysis of suicides committed in podgorica during 1995–1999 period

    Page :359-359

    L. Injac, T. Bakovic, O. Vukovic

    
  • ·P01.148 Hypovitaminosis E in major depression

    Page :359-359

    A. Herran, M.T. de la Maza, M.T. Garcia-Unzueta, J.A. Amado, M.D. Fernandez, J.L. Vazquez-Barquero

    
  • ·P01.149 A comparative P300 study of young adult patients with depressive and depressive-delusional disorders

    Page :360-360

    I.S. Lebedeva, V.G. Kaleda, I.V. Oleichik

    
  • ·P01.150 Multidiscipline approach to prediction of schizophrenia in families

    Page :360-360

    V.A. Orlova, V.I. Trubnikov, T.D. Savina, I.S. Lebedeva, M.V. Alfimova, L.G. Uvarova, N.Yu. Savvateeva

    
  • ·P01.151 A controlled study comparing psychose hallucinatoire chronique” with two matched groups of schizophrenia is consistent with the independency of the two diagnosis

    Page :360-360

    C. Dubertret, P. Gorwood, J. Adés

    
  • ·P01.152 Cognitive performance in chronic alcoholism related to APO E genotype

    Page :360-361

    D. Bartrés-Faz, I.C. Clemente, M. Monrás, A. López-Alomar, P. Moral, M. Sánchez-Turet, C. Junqué

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.153 Schizotypy and handedness

    Page :361-361

    E. Cyhlarova, G.S. Claridge

    
  • ·P01.154 Alexithymia and chronic low back pain

    Page :361-361

    V. Faia, M. Sarchiapone, R. Bruni, M. Mazza, S. De Risio

    
  • ·P01.155 Psychiatric and endocrine aspects of anorexia nervosa

    Page :361-361

    E. Barbarino, M.A. Satta, M. Sarchiapone, S. De Risio

    
  • ·P01.156 Dissociation and body image in a sample of eating disorder patients

    Page :362-362

    G. Faragalli, M. Riccio, C. Giorgio, A. Mei, G. Pozzi, A. Ciocca, S. De Risio

    
  • ·P01.157 Dream as an index of psychic modifications

    Page :362-362

    A. Salone, G. Ruggeri, M. Sarchiapone, S. De Risio

    
  • ·P01.158 Short-term risperidone in anorexia nervosa: A case series

    Page :362-362

    M. Riccio, G. Pozzi, G. Conte, A. Ciocca, S. De Risio

    
  • ·P01.159 Trauma, memory and dissociation: 3 clinical experiences and a research proposal

    Page :362-363

    M. Mazza, M. Sarchiapone, V. Faia, P. Bria, S. De Risio

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.160 A comparative study of venlafaxine versus buspirone in outpatients with generalized anxiety disorder: Preliminary results

    Page :363-363

    L. Sevincok, H. Kaynak, F. Dereboy, A. Uslu, F. Baklac

    
  • ·P01.161 The man who lives in a bath tube. Chronic pain: A case report

    Page :363-363

    S. Uguz, Y.E. Evlice, I. Bilgen

    
  • ·P01.162 Psychiatric morbidity in the population immigrated from the South-Eastern part of Turkey: A randomised controlled study

    Page :363-363

    Y.E. Evlice, I. Bilgen, S. Uguz, M.L. Soylu, E. Yoldascan

    
  • ·P01.163 For how long can be expected a sustained improvement in schizophrenic patients treated with antipyschotics? A clinical experience with risperidone

    Page :363-364

    J. Gibert, J. Bobes, M. Gutiérrez

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.164 Depression and brain perfusion: A spect study

    Page :364-364

    R. Prikryl, E. Ceskova, A. Zourkova, V. Obrovska, J. Prasek

    
  • ·P01.165 Two cases of risperidone — induced tardive dyskinesia and a review of the literature

    Page :364-364

    L. Lykouras, R. Yannakis, P. Oulis, J. Hatzimanolis

    
  • ·P01.166 Marital status and eating disorders. Analysis of its relevance

    Page :364-364

    F. Fernández-Aranda, D. Bussolotti, R. Solano, A. Badia, L. Giménez, V. Turón, J. Vallejo

    
  • ·P01.167 Stage of change in anorexia and bulimia nervosa. Clinical and therapeutical implications

    Page :365-365

    F. Fernández-Aranda, V. Turón, I. Sánchez, M. Viñuales, M.J. Ramos, J. Vallejo, M. Katzman

    
  • ·P01.168 First major depressive episode among suicide attempters in Hungary

    Page :365-365

    J. Balázs, I. Bitter, Y. Lecrubier, N. Csiszér, J. Koszták

    
  • ·P01.169 Rehabilitation of refugees and forced migrants with social-stress disorders in Russia

    Page :365-365

    E.N. Prokudina, V.N. Prokudin, A.P. Muzychenko

    
  • ·P01.170 A factor analysis of signs and symptoms of the manic episode with Bech-Rafaelsen mania and melancholia scales

    Page :365-366

    A. Rossi, E. Daneluzzo, L. Arduini, O. Rinaldi, M. Di Domenico, C. Petruzzi

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.171 Comorbidity of bipolar mood disorders and unipolar mood disorders with personality disorders

    Page :366-366

    A. Rossi, M.G. Marinangeli

    
  • ·P01.172 Breath carbon monoxide increases during psychiatric hospitalisation

    Page :366-366

    D. Zullino, C. Bron, J. Besson, F. Borgeat

    
  • ·P01.173 Olanzapine improves social dysfunction in cluster B personality disorder

    Page :366-366

    D.F. Zullino, T. Häfliger, Ph. Quinche, M. Stigler

    
  • ·P01.174 Rapid remission of depression after carbamazepine augmentation of venlafaxine

    Page :367-367

    E. Ciusani, D.F. Zullino, C.B. Eap, Ph. Delacrausaz, P. Baumann

    
  • ·P01.175 Drug addiction and sexuality

    Page :367-367

    L. Di Furia, M.C. Forcella, N. Savani, S. Picello, F. Schifano

    
  • ·P01.176 A comparison of sexual offenders in custodial care and in penal institution

    Page :367-367

    S. Harsch, U. Jockusch, F. Keller

    
  • ·P01.177 White matter lesions and chronicity of depression

    Page :368-368

    A. Heiden, K. Kettenbach, P. Fischer, B. Schein, A. Bassalamah, R. Frey, T. Gulesserian, U. Itzlinger, S. Trattnig, H. Imhof, S. Kasper

    
  • ·P01.178 Phenelzine efficacy in refractory social phobia: A case series

    Page :368-368

    T.F. Aarre

    
  • ·P01.179 Psychodynamic factors affecting the compliance of psychiatric patient to medication

    Page :368-368

    I. Vartzopoulos, M. Angelopoulou, O. Gasparatou, G. Skourletos, E. Tzebelikos

    
  • ·P01.180 MRI in patients with social phobia

    Page :368-369

    N. Baková, J. Raboch, J. Obenberger, J. Leština

    Résumé Résumé Plan Plan

• Symposia

  • ·P01.181 Thyroid axis alterations in psychoses

    Page :369-369

    D. Degner, V. Schlautmann, J. Kornhuber, E. Rüther, S. Bleich

    
  • ·P01.182 Some personal psychotherapeutic experience in a Moscow's district

    Page :369-369

    V. Skavych

    
  • ·P01.183 Atypical antipsychotic & rehabilitation program in a munchausen's syndrome (case report)

    Page :369-369

    M.T. Marques Pinto, L. Santos

    
  • ·P02.183 Lipid peroxidation after electroconvulsive therapy

    Page :371-371

    S. Bleich, D. Definer, S. Kropp, J. Pilz, E. Riither

    
  • ·P02.184 Saliva methanol values in alcohol withdrawal

    Page :371-371

    S. Bleich, E. Rfither, D. Definer, R. Sprung, J. Kornhuber

    
  • ·P02.185 The schizophrenic communication scale (SCD): A measure of schizophrenic dissociation

    Page :371-371

    N. Bazin, Y. Sarfati, C. Passerieux, M.C. Hardy-Bayle, C.H. de Versailles

    
  • ·P02.186 Anxiety and depression in family members of ICU patients: Ethical considerations regarding decision-making capacity

    Page :372-372

    F. Pochard, E. Azoulay, S. Chevret, I. Ferrand, J.F Dhainaut, B. Schlemmer

    
  • ·P02.187 Psychiatry for medical students in resource poor countries: a description of the curriculum at Malawi's medical school

    Page :372-372

    H. Herzig

    
  • ·P02.188 ¹H-Magnetic resonance spectroscopy at 3.0 tesla reveales reduced n-acetyl aspartate, choline and myo-inositol levels in depression

    Page :372-372

    R. Frey, S. Gruber, G. Ortwein-Swoboda, A. Heiden, V. Mlynarik, E. Moser, S. Kasper

    
  • ·P02.189 Measuring depression in schizophrenia: Relationship with negative symptoms

    Page :372-373

    V.P. Kontaxakis, B.J. Havaki-Kontaxaki, S.S. Stamouli, M.M. Margariti, C.T. Kollias, G.N. Christodoulou

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.190 Athens first-episode schizophrenia study: Efficacy of treatment with risperidone

    Page :373-373

    V.P. Kontaxakis, B.J. Havaki-Kontaxaki, S.S. Stamouli, G.N. Christodoulou

    
  • ·P02.191 Athens first episode schizophrenia study: Safety of treatment with risperidone

    Page :373-373

    V.P. Kontaxakis, B.J. Havaki-Kontaxaki, S.S. Stamouli, G.N. Christodoulou

    
  • ·P02.192 Suicidality and clinical symptoms in acute schizophrenic inpatients

    Page :373-374

    B.J. Havaki-Kontaxaki, V.P. Kontaxakis, M.M. Margariti, S.S. Stamouli, C.T. Kollias, G.N. Christodoulou

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.193 Apinarcotherapy — New progressive method of alcohol and drug addiction treatment

    Page :374-374

    I. Krivopalov-Moscvin

    
  • ·P02.194 Amantadine in patients with obsessive-compulsive disorder and borna disease virus-infection

    Page :374-374

    D.E. Dietrich, L. Bode, G. Von Rimon, T. Gödecke-Koch, D. Rada, H. Ludwig, H.M. Emrich

    
  • ·P02.195 Electrophysiological correlates of impaired components of word recognition in depression

    Page :374-374

    D.E. Dietrich, C. Waller, D. Rada, S. Johannes, H.M. Emrich, T.F. Müntel

    
  • ·P02.196 Inpatient vs. day treatment of alcoholics. Preliminary results of a controlled. Randomized study

    Page :374-375

    G. Weithmann, M. Hoffmann, H. Rothenbacher

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.197 Decoding of emotional facial expression in alcoholics

    Page :375-375

    B. Hermstein, H.C. Trauel

    
  • ·P02.198 Subject selection for the placebo- and comparator-controlled trials of neuroleptics in schizophrenia

    Page :375-375

    P. Mohr, P. Czobor

    
  • ·P02.199 Physical anhedonia and psychopathology: A study in a population of schizophrenic patients

    Page :375-375

    C.T. Kollias, V.P. Kontaxakis, E. Petridou, B.J. Havaki-Kontaxaki, S. Stamouli, D. Trichopoulos, G.N. Christodoulou

    
  • ·P02.200 Social anhedonia and psychopathology: A study in a population of schizophrenic patients

    Page :376-376

    C.T. Kollias, V.P. Kontaxakis, E. Petridou, B.J. Havaki-Kontaxaki, M. Margariti, D. Trichopoulos, G.N. Christodoulou

    
  • ·P02.201 Ad early response and remission of venlafaxine (ven: effexor®) and fluoxetine (flu: prozac®) in geriatric outpatients

    Page :376-376

    A.F. Schatzberg, M. Cantillon

    
  • ·P02.202 Remission rates with different dosages of ven (ven) versus ssris and PBO (PBO) in major depressive disorder

    Page :376-376

    R. Entsuah

    
  • ·P02.203 Response and remission with venlafaxine, SSRIs, or placebo in different subpopulations with major depression

    Page :376-377

    R. Entsuah

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.204 Venlafaxine demonstrates superior sustained remission compared with ssris or placebo

    Page :377-377

    R. Entsuah

    
  • ·P02.205 From classical neurology to neurology of self. The reception of history of neurology and its systematic position in the work of O.W. Sacks

    Page :377-377

    E.H. Hische

    
  • ·P02.206 Electrophysiological correlates of changed cognition in patients with obsessive-compulsive disorder

    Page :377-377

    D. Radar, D.E. Dietrichr, S. Johannes, H.M. Enuich, T.F. Münte

    
  • ·P02.207 Bone mineral density in adult with history of treatment of anorexia nervosa

    Page :377-377

    G. Jagielska, T. Wolanczyk, C. Tomaszewicz-Libudzic, J. Komender, J. Przedlackil, K. Ostrowski, E. Musial, A. Dwornik

    
  • ·P02.208 Anxiety, hyperventilation and cerebral hypoxia: is aerobic exercise good for your brain?

    Page :378-378

    L. Dratcu

    
  • ·P02.209 Serial sexual offenders: brain's predisposition

    Page :378-378

    O.A. bukhanovskaya

    
  • ·P02.210 The menstrual cycle phase and the therapeutic response in schizophrenic women

    Page :378-378

    I. Vanǔrova, A. Yamamotová

    
  • ·P02.211 Burnout among hospital and community based mental health staff

    Page :378-379

    V. Bozikasl, V. Kioseogloul, M. Palialial, I. Nimatoudis, A. Iakovides, I. Diakoyanni-Tarlatzisl, A. Karavatos, G. Kaprinis

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.212 Effects of child homicide in the quality of maternal care: A case report

    Page :379-379

    I. Savvidou, V. Bozikas, A. Pitsavas, A. Karavatos

    
  • ·P02.213 Topiramate in the treatment of mania

    Page :379-379

    V. Bozikas, P. Petrikis, A. Karavatos

    
  • ·P02.214 Therapeutic efficacy and metabolic peculiarities in patients with depressive disorders under tianeptine (TIA) and sertraline (SER) treatment

    Page :379-379

    N. Maximova, E. Misionzhnik, O. Vertogradova, M. Usbekov

    
  • ·P02.215 Adolescents and suicide attempts

    Page :379-380

    D. Anagnostopoulos, H. Lazaratou, I. Amvraziadou, G. Vaslamatzis

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.216 Acute admissions of foreign born people in a closed psychiatric ward

    Page :380-380

    M. Ruiz Ruiz, J.M. Pena-Andrew, J. Torres Ojeda, F. Gonzalez Escalante, A. Rodriguez Rosado, P. Cano Dominguez

    
  • ·P02.217 Clinical course of depression and platelet serotonin uptake

    Page :380-380

    Z. Fišar, I. Paclt

    
  • ·P02.218 Cyamemazine: A revision of its therapeutical anxiolytic profile based on its recently described anti-serotoninergic activity

    Page :380-380

    F. Radat, R. Garay, F. d'Alché-Birée, M. Dib

    
  • ·P02.219 Energy stores in alzheimer's disease (AD)

    Page :380-381

    F. Abalan

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.220 Transcultural adaptation and validation of the quality of life questionnaire

    Page :381-381

    E. Libigerova, H. Müllerová, M. Prouzová, M. Blazkova, P. Matejkova, J. Krepela, J. Mrozek

    
  • ·P02.221 Prevalence of depression (short version of depression questionnaire): Sociologic issues

    Page :381-381

    N.A. Kornetov, E.D. Schastny

    
  • ·P02.222 Suicidal behavior in adolescence in Eestern Siberia

    Page :381-381

    A.N. Kometov, N.A. Kometov

    
  • ·P02.223 Phenomenological aspects of dissociative experiences in depressive and substance abuse pathology

    Page :381-382

    L. Severino, M.L. Figueira

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.224 Antidepressant evoked alterations of transmembrane cell signalling

    Page :382-382

    H. Kovářú, A. Fišerová, F. Kovářú, Z. Fišar, V. Lisá, I. Malbohan

    
  • ·P02.225 Wisconsin card sorting test performance in subclinical obsessive-compulsive subjects: Relation to symptom dimensions

    Page :382-382

    D. Mataix-Cols, M. Aleu, C. Junqué, M. Sanchez-Turet

    
  • ·P02.226 Psychotropic treatment and weight gain

    Page :382-382

    S. Stella, A. Ravera, F. De Santis, C. Persichella, N. Gosio, C. Rizzoli

    
  • ·P02.227 Comparison of the coronary heart disease risk factor profile of risperidone vs olanzapine treated patients

    Page :382-383

    R.H. Bouchard, J. Villeneuve, N. Alméras, I. Simoneau, M.F. Demers, C. Cadrin, M.A. Roy, J.P. Mortard, J.P. Despres

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.228 Sexual dysfunction burden in a 24-week study of SSRIS in depressed patients

    Page :383-383

    L. Ekselius, H. Agren, A. Aberg-Wistedt

    
  • ·P02.229 A placebo-controlled study of sertraline in generalized social phobia

    Page :383-383

    M. Van Ameringen, R. Swinson, J.R. Walker, R.M. Lane

    
  • ·P02.230 Sertraline versus imipramine in non-melancholic depression

    Page :383-384

    E. Baca, M. Gonzalez de Chavez, M. Garcia-Toro, F. Perez-Arnau, A. Rives, B. Penasa, S. Olivaros, J. Espejo, A. Porras, R. Lane

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.231 24-week prevention of relapse of generalized social phobia study in responders to 20-weeks of sertraline treatment

    Page :384-384

    M. Van Ameringen, R. Swinson, J.R. Walker, R.M. Lane

    
  • ·P02.232 Impact of residual symptoms on outcomes in GAD: Evidence from placebo-controlled trials of venlafaxine er

    Page :384-384

    J.G.C. Rasmussen, D. Hacken, P. Meoni, C. White

    
  • ·P02.233 Influence of selected ssri on activity of cytochrome p450 2di and arylamine N-etyltransfearase in wistar rats

    Page :384-385

    Z. Justinova, K. Nerusilova, E. Hadasova, M. Tomandloval

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.234 Biphasic effects of cannabinoids on leukocyte phagocytosis in mice

    Page :385-385

    J. Vinklerova, J. Nováková, A. Šulcová

    
  • ·P02.235 Biological markers of the hyperkinetic syndrome in children of age 6 to 10 years

    Page :385-385

    I. Paclt, P. Uhlíková, J. Koudelová, P. Bauer, M. Vaněčková, V. Mat'oška, A. Bóday, Z. Saidl

    
  • ·P02.236 ECG mapping with a view to ischemic changes of a myocardium in patients with a panic disorder

    Page :385-385

    I. Paclt, K. Pišvejcová, J. Slaviček, O. Kittnar

    
  • ·P02.237 Mirtazapine: A quick and effective treatment in patients with depression-related anxiety symptoms

    Page :385-386

    J. Ladner, A.A. Nimmerrichter

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.238 Psychiatric disorders and psychiatric treatment in ecstasy users compared to users of other illicit drugs and controls in a representative sample of young germans

    Page :386-386

    C.G. Schütz, R. Lieb, H. Pfister, U. Wittchen

    
  • ·P02.239 Family study of suicidal behaviour in bipolar disorder

    Page :386-386

    P. Cavazzoni, B. Ahrens, A. Berghöfer, A. Duffy, E. Grof, B. Mfller-Oerlinghausen, P. Zvolský, P. Grof, M. Alda

    
  • ·P02.240 Are conventional antipsychotics the only option for the treatment of first episode schizophrenia?

    Page :386-386

    M.Yu. Popov

    
  • ·P02.241 The ideological dimensions of the burnout syndrome in psychiatric institutions

    Page :386-387

    E. Lozinskaya, V.M. Bekhtererev

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.242 Delivering information to schizophrenic patients: A review of available studies

    Page :387-387

    D. Gerard, N. Bazin, P. Nuss, P. Fremont, M. Ferreri

    
  • ·P02.243 Schizophrenia and parkinsonism vs. lateralization

    Page :387-387

    D. Marinkovic

    
  • ·P02.244 Neuropsychological impairments and symptoms of schizophrenia

    Page :387-387

    S. Klingberg, R. Gutjahr, A. Wittorf, G. Wiedemann

    
  • ·P02.245 External validity of randomised clinical trials (RCT'S): Is there a selection bias in psychotherapy treatment studies of schizophrenia?

    Page :387-388

    G. Wiedemann, S. Klingberg, A. Wittorf, A. Fischer, G. Buchkremer

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.246 The effects of restrictive diet in gluten kasein sensitive autistic persons — (pilot study)

    Page :388-388

    L. Aneta, S. Milijana, L. Dragan, M. Ivona

    
  • ·P02.247 Quality of life in a danish sample of schizophrenic inpatients

    Page :388-388

    V. Noerholm

    
  • ·P02.248 Major depression and psychological well-being in the general danish population

    Page :388-388

    L. Raabæk Olsen, V. Norholm, N.-A. Rasmussen, T. Watt, M. Grønvold, J. Bjømer, P. Bech

    
  • ·P02.249 Factors associated with therapeutic effect of risperidone on psychopathology and working memory in schizophrenic patients

    Page :389-389

    A. Borkowska, A. Kućma, J.K. Rybakowski

    
  • ·P02.250 Factors predicting depression among male and female in an Arab community

    Page :389-389

    R. Ghubash, T.K. Daradkeh, M.T. Abou-Saleh

    
  • ·P02.251 Depression in patients with fabry disease

    Page :389-389

    S.V Kopishinskaya, A.V Gustov

    
  • ·P02.252 Neurobehavioural study of long-term peroral administration of dehydroepiandrosterone in old rats

    Page :389-390

    H. Tejkalová, R. Hampj, M. Bičíková, P. Hušek, Z. Krištofikovál, O. Benešovál

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.253 Personality in patients with chronic fatigue syndrome compared to depressed patients

    Page :390-390

    M. Schlöǵelhofer, U. Willinger, U. Itzlinger, Ch. Wolf, U. Bailer, H.N. Aschauer

    
  • ·P02.254 TPQ, in functional dysphonia

    Page :390-390

    U. Willinger, H.N. Aschauer

    
  • ·P02.255 The relationship between alzheimer's disease, early onset and late-onset depression in the elderly assessed in a family study

    Page :390-390

    R. Heun, A. Papassotiropoulos, F. Jessen, W. Maier, J.C.S. Breitner

    
  • ·P02.256 Sleep in OCD: A correlational study

    Page :390-391

    A. Matos-Pires, F. Cavaglia, A. Atalaia, E. Lara, F. Arriagal

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.257 Clinical assessment of sleep in OCD: A comparative study

    Page :391-391

    A. Matos-Pires, F. Cavaglia, E. Lara, F. Arriaga

    
  • ·P02.258 Psychiatry of extremal situations

    Page :391-391

    V.N. Krasnov

    
  • ·P02.259 Development of psychiatric care network in Russia

    Page :391-391

    B.A. Kazakovtsev

    
  • ·P02.260 Delivering aid to the victims of man-caused disasters and acts of terrorism

    Page :392-392

    A.O. Bukhanovsky

    
  • ·P02.261 Long-term trends of symptoms and of disability in schizophrenia and related disorders

    Page :392-392

    K. Ganev, G. Onchev

    
  • ·P02.262 Prevalence of personality disorders among alcoholic patients

    Page :392-392

    B. Bodnár, E. Pálová, I. Lukácsová, L. Medvecká, M. Kovaničová, K. Kubašovská

    
  • ·P02.263 Do amitriptyline and citalopram differ in the effect on membrane characteristics of rat cardiomyocytes in culture?

    Page :392-393

    J. Hamplová, J. Krůšek, I. Paclt, J. Slaviček, V. Lisá

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.264 Antidepressant therapy and heart electric field: Quantitative aspects

    Page :393-393

    I. Paclt, J. Slavíček, A. Dohnalová, O. Kittnar, K. Pišvejcová, E. Kitzlerová

    
  • ·P02.265 Efficacy and tolerability of reboxetine used by elderly depressed patients

    Page :393-393

    J. de la Gándara, P. Such

    
  • ·P02.266 Why is length of stay in psychiatric clinics exponentially distributed? An analysis of contributing factors

    Page :393-393

    A. Stevens, K. Hammer, G. Buchkremer

    
  • ·P02.267 Unimpaired perception, but impaired working memory and motor retardation in borderline patients

    Page :393-394

    A. Stevens, M. Nickola, M. Burkhardt, N. Rosellen

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.269 Attitudes and perceptions related to drug abuse in a sample of Greek users, ex-users and professional workers

    Page :394-394

    J. Liappas, E. Mellos, P. Papavasiliou, G.N. Christodoulou

    
  • ·P02.270 Attitudes and perceptions of professional workers facing drug addiction problems

    Page :394-394

    J. Liappas, E. Mellos, P. Papavasiliou, G.N. Christodoulou

    
  • ·P02.271 Pharmacokinetic drug interaction potential of risperidone as assessed by the dextromethorphan, the caffeine and the mephenytoin test

    Page :394-395

    C.B. Eap, G. Bondolfi, D. Zullino, C. Bryois, M. Fuciec, L. Savary, M. Jonzier-Perey, P. Baumann

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.272 Follow up study of atypical antipsychotics for patients with psychiatric disorders and intellectual disability

    Page :395-395

    M. Vanstaelen, N. Bouras, G. Holt, J. Martin

    
  • ·P02.273 10 year follow up of a scottish schizophrenia cohort

    Page :395-395

    M.G. Livingston, R. Ward, M. McLaughlin

    
  • ·P02.274 Training model in psychotherapy for general physicians

    Page :395-395

    J. Beran

    
  • ·P02.275 Weight gain with antipsychotic medication — two years follow up study

    Page :395-395

    V. Lívia, K. Soña, K. Mariana

    
  • ·P02.276 The impact of huntington's disease on caregivers: The czech experience

    Page :395-396

    J. Roth, T. Uhrová, P. Doubek, M. Preiss, J. Židovská

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.277 Autonomic neurocardiac regulation (ANR) in patients with major depression and effects of antidepressive treatment with reboxetine

    Page :396-396

    M.W. Agelink, B. Baumann, W. Lemmer, E. Klieser

    
  • ·P02.278 Effects of sildenafil (viagra®) on cardiovascular autonomic function (CAF) in man: Preliminary results

    Page :396-396

    M.W. Agelink, T. Majewski, T. Schmitz, M. Mück-Weymann

    
  • ·P02.279 The cardiovascular safety profile of amisulpride in man: Results of an open clinical study

    Page :397-397

    M.W. Agelink, F.X. Eich, E. Klieser

    
  • ·P02.280 Testosterone, ageing and coital activity

    Page :397-397

    S. Pietrucha, J. Raboch, J. Raboch

    
  • ·P02.281 Functional magnetic resonance imaging of reaction to food presentation in anorexia nervosa

    Page :397-397

    U. Rudolf, P. Hana, O. Jiři, K. Jan

    
  • ·P02.282 The prevalence of depression in the Czech Republic

    Page :397-398

    D. Vanek, J. Raboch, J. Vanek

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.283 The relationship between aspects of trait impulsivity and impulsive suicidal behavior

    Page :398-398

    B. Ripke

    
  • ·P02.284 Transgenic mice overexpressing brain human amyloid precursor protein show an age-dependent cognitive impairment in the morris water maze

    Page :398-398

    M. Ort, M. Koistinaho, R. Vondrous, J.M. Cimadevilla, J. Koistinaho, L.S. Higgins, J. Bures

    
  • ·P02.285 Could anorexia be considered as an addiction?

    Page :399-399

    F. Levy, J. Behm, J.M. Pinoit

    
  • ·P02.286 Agitation and aggressiveness among French elderly resident

    Page :399-399

    J.-M. Leger, R. Moulias, P.H. Robert, B. Vellas, M. Micas, K. Djaballah

    
  • ·P02.287 The psychophysic relaxation and neuroticism in the children with cerebral palsy

    Page :399-399

    I. Slaviček

    
  • ·P02.288 Biological factors in female sexual development

    Page :399-399

    J. Raboch, J. Hořejšsi, J. Raboch

    
  • ·P02.289 Study of the cyclothymic temperament scale in controls and relatives of mood disorder patients [depressive and bipolar]

    Page :399-400

    P. Chiaroni, E. Hantouche, J. Gouvernet, J.-M. Azorin

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.290 The nicotine dependence in inpatients with schizophrenia and schizoaffective disorder

    Page :400-400

    P. Fridrich, T. Morcinek, M. Pošmurová, I. Zukov

    
  • ·P02.291 Cholesterol concentrations in high and low women suicide attempters

    Page :400-400

    J. Vevera, I. Žukov, T. Morcinek

    
  • ·P02.292 Tradition, clinical needs and economy: Their effects on the development of neuro-psychopharmacology: Czech and Slovak experience

    Page :401-401

    O. Vinat

    
  • ·P02.293 Navigation and it's idiothetic and allothetic components in healthy young humans

    Page :401-401

    K. Stepankova, A.A. Fenton, J. Bures, M. Kalina, V.D. Bohbot

    
  • ·P02.294 Post-traumatic stress disorder in a student population several years after bomb attack

    Page :401-401

    J. De Mol, D. Lecompte, I. Pelc

    
  • ·P02.295 Agression and PTSD: Medicolegal evaluation

    Page :401-402

    J. De Mol, D. Lecompte, I. Pelc

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.296 Observation of an embarassing” effect during the initial phase of treatment with olanzapine on the subjective experience in three longstay schizophrenic patients with promiment negative symptoms

    Page :402-402

    C.V. de Blécourt, P.J.S. Michielsen, W.M.A. Verhoeven

    
  • ·P02.297 Sildenafil citrate (viagra) treatment of sexual dysfunction in schizophrenic patient

    Page :402-402

    I. Reznik, R. Benatov, Z. Zemishlany

    
  • ·P02.298 Switching from conventional to new atipical antipsychotics in schizophrenic patients: A study on patient's satisfaction

    Page :402-402

    G. Bartkó, L. Simon, T. Tüske, E. Linka, H. Váradi, T. Szabó

    
  • ·P02.299 Early onset of schizophrenia and efficacy of risperidone

    Page :402-403

    I. Drtíková

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.300 Gender differences in psychiatric admissions: The influence of culture and social psychiatry

    Page :403-403

    Y. Amin, E. Hamdi

    
  • ·P02.301 Life quality in a group of elderly people who are non-sufficient, and non institutionalized

    Page :403-403

    S. Fassino, G.Abbate Daga, P. Leombruni, A. Brustolin, I. Garzaro, F. Amianto, G. Lazzarini, F. Fabris, G.G. Rovera

    
  • ·P02.302 Bulimic family dynamics: Temperament and character dynamics

    Page :403-404

    S. Fassino, G.Abbate Daga, P. Leombruni, F. Amianto, M. Levi, F. deDominicis, G.G. Rovera

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.303 Study of psychotic disorders with artificial neural networks

    Page :404-404

    J.V. Rodado, M.J. Rodado, J.M. Chamizo, F. Iborra, B. Ledesma, J. Mora, D. Barcia

    
  • ·P02.304 Predicting outcome of first episodes of schizophrenia

    Page :404-404

    M.J. Rodado, J.V. Rodado, J. Hernandez

    
  • ·P02.305 A comparison of English and Italian drug legislation, their policies of intervention and any consequences upon stress and burnout at work

    Page :404-405

    M. Barbo

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.306 Smooth pursuit eye movement (SPEM) in bulimia nervosa

    Page :405-405

    K. Hynek, M. Anders

    
  • ·P02.307 Alexithymia correction at hypertension patients with affective disoders

    Page :405-405

    B.G. Goldin, O.M. Gilinskaya, M.V. Cherkalina

    
  • ·P02.308 Psychiatric co-morbidity among amphetamine users: Relations to amphetamine-induced psychosis

    Page :405-405

    C.-K. Chen, S.-K. Lin, P. Sham, D. Ball, E.-W. Loh, R. Murray

    
  • ·P02.309 Psychiatric morbidity among juvenile drug offenders

    Page :405-406

    C.-F. Yen, M.-Y. Chong, Y.-H. Liu

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.310 Working with schizophrenic people: Informations to their families

    Page :406-406

    R. Bosio, S. Salomoni

    
  • ·P02.311 Coping strategies in relatives of patients with schizophrenia

    Page :406-406

    F. Osterman, M.Z. Dernovšek, R. Tavèar, V. Novak-Grubiè

    
  • ·P02.312 Violence and crime: Psychiatric approach

    Page :406-406

    G.F. Eleta, C.L. Gatti, R.A.Sotelo Largo

    
  • ·P02.313 Forensic psychiatric study of sexual abuse

    Page :406-407

    J.C. Romi, L.Garcia Samartino, G.F. Eleta, C.L. Gatti, M. Gaziglia

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.314 The wessex recent inpatient suicide study: 1. Case-control study of 234 recently discharged psychiatric inpatient suicides

    Page :407-407

    D.S. Baldwin, J.M.A. Sinclair, E.E. King

    
  • ·P02.315 The wessex recent inpatient study: 2. Case-control study of 59 inpatient suicides

    Page :407-407

    J.M.A. Sinclair, D.S. Baldwin, E.A. King

    
  • ·P02.316 Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (efeso study)

    Page :407-407

    J.C. Gomez, J.A. Sacristan, E. Edgell, M.Gonzalez de Chavez, S. Gavart

    
  • ·P02.317 Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia

    Page :408-408

    E.T. Edgell, W.Scott Andersen, B.M. Johnstone, B. Dulisse, D. Revicki, A. Breier, S. Gavart

    
  • ·P02.318 Global index of safety (GIS): A new instrument to assess drug safety: Application to a prospective pharmacoepidemiological study (EFESO)

    Page :408-408

    J.A. Sacristán, J.C. Gómez, X. Badia, P. Kind, S. Gavart

    
  • ·P02.319 Antipsychotic treatment, adverse events and health-related quality of life

    Page :408-408

    X. Badia, A. Casado, J.A. Sacristán, J.C. Gómez, K.J. Gregor, S. Gavart

    
  • ·P02.320 Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study)

    Page :409-409

    J.C. Gomez, J.A. Sacristan, P.R. Carrasco, E. Alvarez, J. Bobes, F. Cañas, J. Gascon, J. Gibert, M. Gutierrez

    
  • ·P02.321 Occurrence of CYP2D6 gene duplication in Hong Kong Chinese

    Page :409-409

    L.Y. Chow, M. Garcia-Barceló, K.L. Lam, H.F.K. Chiu, Y.K. Wing, M.M.Y. Waye

    
  • ·P02.322 Effectiveness of biological and non biological treatments in schizophrenia

    Page :409-409

    P.L. Marconi, L. Fonticoli

    
  • ·P02.323 Autonomic disturbance in malignant catatonia

    Page :409-410

    A. Ruiz, Ma.M. Laya, R. Coronas, C. Doménech, G. García, N. García, S. Escoté

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.324 Diagnosing psychiatric comorbidity in a drug-addiction unit

    Page :410-410

    M. Astals, D. Serrano, G. Pérez, R. Marti-Santos, C. Castillo, M. Torrens

    
  • ·P02.325 Residential care in Andalusia and London: A comparison

    Page :410-410

    N. Trieman, F. Torres-Gonzalez, C. Rickard, J.C. Maestro, M. Laviana, B. Moreno-Küstner

    
  • ·P02.326 Standardised description of psychiatric care. The need to place every service in its specific context

    Page :410-410

    C. Munizza, G. Tibaldi

    
  • ·P02.327 The influence of the computerized management system in the philosophy of the department of mental health of North East Italy

    Page :410-411

    M. Del Pin, M. Marin, V. Giorgio

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.328 The big five inventory: The French version

    Page :411-411

    O. Plaisant, O.P. John, S. Srivastava, G.A. Mendelsohn

    
  • ·P02.329 Atypical versus conventional antipsychotic medication: Impact on subjective quality of life of patients with schizophrenia or related disorders

    Page :411-411

    R. Tempier, N. Pawliuk

    
  • ·P02.330 Cost of a manic episode in bipolar disorder: A French study

    Page :411-411

    J.-P. Olié, E. Levy, J. Spiesser

    
  • ·P02.331 Medication management of a manic episode in bipolar disorder: A French study

    Page :411-412

    J.-P. Olié, E. Levy, P. Carita

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.332 Schizotypy and hypomania as correlates of creative achievement

    Page :412-412

    B.T.C. Miller

    
  • ·P02.333 Switching to amisulpride: Findings from a retrospective questionnaire

    Page :412-412

    J.P. Chabannes, A. Giudicelli, S. Farah, D. Gerard

    
  • ·P02.334 The effect of amisulpride on affective and social negative syndromes in schizophrenia

    Page :412-412

    A. Braconnier, P. Lessieur, P. Martin, K. Djaballah, D.A. Gerard

    
  • ·P02.335 Pattern of prescription of antipsychotic drugs in psychiatric departments

    Page :412-413

    F. Rouillon, P. Nuss, K. Djaballah, D.A. Gerard

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.336 Assessing the impact of delivering information to schiizophrenic patients: The soleduc program

    Page :413-413

    P. Nuss, D.A. Gerard, M. Ferreri

    
  • ·P02.337 Use os atypical antipsychotics in the emergency department of psichiatry

    Page :413-413

    A. D'ambrosio, F. Laura, R. Petrone

    
  • ·P03.338 Experiences with the open-door-system in a adult inpatient psychiatric unit in a German general hospital

    Page :413-414

    A. Dippel, I. Munk, K. Demisch

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.339 Reliability and validity of the psychosocial aptitude and efficacy rating scales (PARS) in a schizophrenic patient sample

    Page :414-414

    G. Darcourt, P. Martin, D. Lethuaire, C. Ferretti, D. Gérard

    
  • ·P02.340 Predictive factors for mental health in patients admitted for ischaemic cardiopathy in auniversity hospital in the south of Spain

    Page :414-414

    J. Elorza, I. Ramos, F. Fernandez-Palacin, I. Failde

    
  • ·P02.341 Depressive syndrome in schizophrenia — A psychosocial aspect

    Page :414-414

    Lj. Leposavić, G. Nikolić-Balkoski, J. Barišić, Z. Barac, S. Milovanović

    
  • ·P02.342 Six-month outcome of electroconvulsive therapy and repetitive transcranial magnetic stimulation treatment in severely depressed patients

    Page :414-415

    P.N. Dannon, L. Grunhaus, O.T. Dolberg, S. Schreiber

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.343 Electroconvulsive therapy is effective in the treatment of patients who failed to respond to a course of repetitive transcranial magnetic stimulation

    Page :415-415

    P.N. Dannon, R. Amiaz, S. Schreiber, L. Grunhaus

    
  • ·P02.344 Repretitive transcrainial magnetic stimulation is effective as the first time in the treatment of relapse of depression

    Page :415-415

    P.N. Dannon, S. Schreiber, O.T. Dolberg, L. Grunhaus

    
  • ·P02.345 Literacy rate, gross domestic product and suicide rate in 33 European countries

    Page :415-415

    A. Marušic, M. Khan, A. Farmer

    
  • ·P02.346 Correlation between suicide risk, time spent in prison and vulnerability profile of people in confinement

    Page :415-416

    P. Frottier, K. Ritter, S. Frühwald, F. König, P. Bauer

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.347 Deprivation versus importation: A model explaining the increase of suicide rates in custody

    Page :416-416

    P. Frottier, K. Ritter, S. Frühwald, S. Lehr, P. Bauer

    
  • ·P02.348 Psychopathology in patients with treated Wilson's disease

    Page :416-416

    K. Portala, L. Ekselius, L. von Knorring

    
  • ·P02.349 What are the skills required for general practice and paediatrics as FAS as the psychopathology of children and adolescents is concerned?

    Page :416-416

    L. Philippe, E. Lemonnier, J. Jouquan, A. Lazartigues

    
  • ·P02.350 The assessment and treatment team: A new approach to mental health services in conventry

    Page :416-417

    N.M.J. Burley, S.J. Tripp, A.Ashley Smith

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.351 Al Ain community survey of psychiatric morbidity III: The natural history of psychopathology and the utilization rate of psychiatric services in Al Ain

    Page :417-417

    T.K. Daradkeh, R. Ghubash, M.T. Abou-Saleh

    
  • ·P02.352 Depression and anxiety in coronary artery bypass grafting patients

    Page :417-417

    J. Rymaszewska, A. Kiejna

    
  • ·P02.353 Relationship between cognitive function and interpersonal problem-solving skills in schizophrenic patients compared to healthy subjects

    Page :417-418

    Ph. Huguelet, A. Zanello

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.354 Annoucement of diagnosis of schizophrenia

    Page :418-418

    J.C. Seznec, G. Saba, L. Stamatiadis, A. Lefort, J.F. Rocamora, D. Januel

    
  • ·P02.355 Comedication in psychiatric illneses

    Page :418-418

    L.K. Montane Jaime, M. Ackenheil

    
  • ·P02.356 Mental health support for war refugees

    Page :418-418

    W. Rutz, L. Urbina, H. Wahlberg

    
  • ·P02.357 Comparison of the treatment outcome measures in panic disorder

    Page :418-419

    V. Starcevic, G. Bogojevic, M. Latas, D. Kolar

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.358 Mid life women, depression and somatisation

    Page :419-419

    M.M.M.P. Van Moffaert

    
  • ·P02.359 Tianeptine for the treatment of major depressive episode: A double-blind study versus fluoxetine

    Page :419-419

    F. Faltus, V. Novotný, J. Raboch, I. Žucha

    
  • ·P02.360 Differences in echogenicity of substantia nigra in patients with different subtypes of the schizophrenic spectrum

    Page :419-420

    B. Jabs, D. Berg, U. Merschdorf, B. Pfuhlmann, A.J. Bartsch, K.V. Toyka, H. Beckmann, G. Becker

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.361 P300 amplitude over temporal regions in schizophrenia: An investigation using Japanese subjects

    Page :420-420

    A. Iwanami, N. Kato, K. Kasai, S. Kamio, S.-i. Furukawa, M. Fukuda, K. Nakagome, Y. Okajima, H. Isono, K. Kamijima

    
  • ·P02.362 Interventions of medico-psychological emergency teams in France

    Page :420-420

    P. Louville

    
  • ·P02.363 GHB treatment of alcohol and drug addiction

    Page :420-420

    L. Tarricone

    
  • ·P02.364 Efficacy of antidepressants in the treatment of severe depression

    Page :420-421

    U. Bailer, H.N. Aschauer, S. Kasper

    Résumé Résumé Plan Plan

• Symposia

  • ·P02.365 Vascular dementia the most frequent cause of dementia: Four year outcome in Kosice

    Page :421-421

    H.M. Shahpesandy, M. Medvecky, E. Palova, S. Kitkova, M. Kafkova, J. Vancikova, M. Murcko, I. Lukacsova

    
  • ·P03.366 Predictors of good prognosis in patients with schizophreniform disorders

    Page :423-423

    I. Iancu, E. Lepkifker, P.N. Dannon

    
  • ·P03.367 Violence in psychiatry. A study on an accreditation program

    Page :423-423

    J.G. Rohmer, B. Kastler

    
  • ·P03.368 Mental health of students. Four years of functionning of specialized institution in Strasbourg

    Page :423-423

    M. Patris, B. Piret

    
  • ·P03.369 Generalized anxiety disorder in dysfunctional families

    Page :423-423

    L. Ben-Noun

    
  • ·P03.370 Effect of axis I comorbidity on bipolar II age at onset

    Page :424-424

    F. Benazzi

    
  • ·P03.371 Psychotic depression: Bipolar II and unipolar

    Page :424-424

    F. Benazzi

    
  • ·P03.372 From amisulpride to rehabilitation

    Page :424-424

    I. Vlokh, S. Mikhnyak, Y. Gorodylovsky

    
  • ·P03.373 Experience of Stablon (tianeptine) administration in neurotic states with anxiety

    Page :424-425

    I. Vlokh, B. Kulyk, R. Bilobryvka

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.374 Visuo-spatial functions in the schizophrenic spectrum

    Page :425-425

    M.C. Hardoy, M.G. Carta, M.J. Hardoy

    
  • ·P03.375 Therapy treatment-resistant depressions

    Page :425-425

    G. Mazo

    
  • ·P03.376 To philosophic statement of a question about mental health in Russian culture

    Page :425-425

    V. Skavych

    
  • ·P03.377 Russian psychoanalysis must correct the Freud's mistake

    Page :425-426

    V. Skavych

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.378 Reboxetine in negative symptoms of schizophrenia

    Page :426-426

    E. Aragüés, P. Malo, L. Pacheco, M. Etxebeste, M. Aragüés, M. Prieto

    
  • ·P03.379 Suicide in Harghita county, 1991–1999. Epidemiological research

    Page :426-426

    A. Veress, G. Vadas

    
  • ·P03.380 Towards systematization of psychotic disorders with sexual content in schizophrenia

    Page :426-426

    K. Danielyan, A.Danielyan Susanna

    
  • ·P03.381 Intentionality and ERPs in the three dimensions of schizophrenia

    Page :426-426

    M. Bertelli, G. La Malfa, V. Pieroni, M. Conte, P. Cabras

    
  • ·P03.382 Coercion and ward resources

    Page :427-427

    K. Rosenberg Andersen

    
  • ·P03.383 Organic asthenic disorder and successful education of preliminary schoolchildren

    Page :427-427

    N. Butorina, G. Butorin

    
  • ·P03.384 About conception of dissocial development in childhood

    Page :427-427

    G. Butorin

    
  • ·P03.385 Depressive disorders at adolescents within penitentionary maladjustment

    Page :427-428

    E. Krivulin, S. Betskov

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.386 Heboid syndrome of residual-organic genesis at preliminary pupils

    Page :428-428

    T. Kolesnichenko

    
  • ·P03.387 Dynamic of psuchomotor disorders of residual organic genesis

    Page :428-428

    E. Malinina

    
  • ·P03.388 Rsychophysical maldevelopment as the reason of deviant behavior in childhood

    Page :428-428

    L. Rychkova

    
  • ·P03.389 Individual social and labour long-term prognosis in attack form schzophrenia

    Page :428-429

    L. Anachkina

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.390 Family therapy in substance abuse disorders

    Page :429-429

    C. Bressi, G. Invernizzi

    
  • ·P03.391 Prevalence and severity of psychiatric co-morbidity in nicotine dependence

    Page :429-429

    M. Riglietta, M. Campana, L. Musitelli, L. Tidone

    
  • ·P03.392 Mental disturbances in persons exposed to radiation after chernobyl NPP accident

    Page :429-429

    I.V. Zdesenko

    
  • ·P03.393 Changings in psychopathology of schizophrenic patients during the NATO intervention in Yugoslavia

    Page :429-430

    G. Nikolić-Balkoski, Lj. Leposavić, J. Barišić-Rojnić, D. Duišin

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.394 The difference of reduction posttraumatic stress disorders treated by standard and retard forms of Xanax

    Page :430-430

    V. Voloshin, L. Kim

    
  • ·P03.395 Therapy of depressive disorders with tianeptin and sertralin in patients with hypertension and ischemic heart disease

    Page :430-430

    K.V. Tarasova, V.N. Krasnov, E.A. Nesterova, I.A. Sadulaeva, T.V. Dovzhenko

    
  • ·P03.396 School for psychophysical self-regulation of diabetes mellitus patients

    Page :430-430

    I. Shybaeva

    
  • ·P03.397 Effect of risperidon on autonomic regulation in patients of affective disorders in period between the relapses

    Page :430-431

    T.S. Melnikova, E.G. Kostyukova, G.M. Granyonov

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.398 Heart rate variability following transcranial magnetic stimulation in major depression

    Page :431-431

    S. Kapiletti, E. Tsukarzi, S. Mosolov

    
  • ·P03.399 The structure of psychosis among patients with contemporary forms of organic damage of brain

    Page :431-431

    E. Maxoutova, E. Jeleznova, L. Socolova, A. Zemlyanaya

    
  • ·P03.400 Xanax-retard in the ambulant treatment of psychogenic depression

    Page :431-431

    V. Makeev

    
  • ·P03.401 Moclobemide and psychodynamic psychotherapy in complex treatment of social phobia

    Page :431-432

    A. Litvinov, L. Gorobetz, V. Vjatkina

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.402 Sexual dysfunctions and endocrynous system in chernobyl patients and those with the CNS's organic deficiencies

    Page :432-432

    V. Krjukov, M. Yurkin

    
  • ·P03.403 Using of the scale derogatis (SCL-90) to diagnose affective disorders

    Page :432-432

    T. Yudeeva, G. Petrova, T. Dovzhenko

    
  • ·P03.404 Therapy of sexual somatization disorders in males

    Page :432-432

    I. Kan

    
  • ·P03.405 Thyroliberin in complex therapy in depressive patients

    Page :432-433

    G. Ivanova

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.406 Pharmacoeconomics of some depot neuroleptics and novel neuroleptics

    Page :433-433

    I. Gurovich, E. Lyubov, A. Shmukler

    
  • ·P03.407 Experience of sexual education of the adolescents

    Page :433-433

    T.N. Grigoryewa, N.N. Steniayewa

    
  • ·P03.408 Mental disorders in acute period of brain concussion

    Page :433-433

    I.V. Dorovskikh

    
  • ·P03.409 Basic remission of heroin dependence: Complex approach

    Page :433-434

    V.A. Galkin

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.410 The influence of the hormonal preparations (zoladex, tamoxiphen) on the clinic and the dynamics of the psychic disorders of the patients with breast cancer

    Page :434-434

    E. Boldova

    
  • ·P03.411 Depressive disorders developing after ovarioectomia

    Page :434-434

    G.Ya. Kamenetstkaya, V.N. Krasnov, S.V. Yureneva, N.G. Pilyaeva

    
  • ·P03.412 Sexual disorders in men-partners of women with vaginism and dispareunia

    Page :434-434

    A. Irina

    
  • ·P03.413 Correction of neurocognitive dysfunction in psychoorganic patients

    Page :434-435

    E. Kosterina, V. Krasnov

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.414 Psychopharmacotherapy of depression in primary care

    Page :435-435

    V. Krasnov, T. Dovjenko, Yu. Rivkina

    
  • ·P03.415 Antioxidant effect of cerebrolysin therapy of psychoorganic syndrome

    Page :435-435

    N. Yermackova, V. Krasnov

    
  • ·P03.416 The experience of practical use of the I-structural G. Ammon test with psychiatric hospital patients

    Page :435-435

    B.S. Polozhy, I.O. Khroulenko-Varnitsky

    
  • ·P03.417 The use of I-structure ista G. Ammon test in psycho-diagnostic research with patients of psychiatric hospital

    Page :435-436

    I.O. Khroulenko-Varnitsky, B.S. Polozhy

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.418 Somatic and neurological complications in drug addicts

    Page :436-436

    I.Y. Kaplan, A.A. Kozlov

    
  • ·P03.419 Symbiosis of psychiatry and neurocomputing, results, problems, perspectives

    Page :436-436

    A.G. Lee, V.D. Zigancov

    
  • ·P03.420 Videocourses on psychiatry

    Page :436-436

    A.G. Lee

    
  • ·P03.421 Antidepressants in heroine addiction treatment

    Page :436-437

    T.A. Kitkina, M.L. Rokhlina

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.422 Computerized assessment of depressive disorders severity

    Page :437-437

    E. Grigorieva

    
  • ·P03.423 Risk factor for psycopathology during residency (postgraduate medical training)

    Page :437-437

    P. Morales, O. Granada, G. Guerrero, J. Lopez-Ibor

    
  • ·P03.424 The most common psychopathological entities at refugees

    Page :437-437

    M. Pejovic, T. Cavic

    
  • ·P03.425 Emergency psychiatry at department for children and adolescent psychiatry — two years follow up

    Page :437-438

    M. Pejovic Milovancevic, N. Ljubomirovic

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.426 Resistant neurotic disorders

    Page :438-438

    N.A. Mauta, V.D. Mishiev, I.A. Yavdak, D.M. Denisenko

    
  • ·P03.427 Prophylaxis of the auto-aggressive behavior among military men of the forces of the ministry of internal affaires of Ukraine

    Page :438-438

    N.A. Maruta, V.S. Gichun

    
  • ·P03.428 Comparison of personality between Japanese major depressive and bipolar patients by the Munich personality test

    Page :438-439

    K. Otsuka, S. Kato

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.429 A comparison of diagnoses according TOGMS-A/AGECAT, DSM-III-R and clinician's definition

    Page :439-439

    R.T. Schaub, M. Linden, J.R.M. Copeland

    
  • ·P03.430 The severity and patterns of use of psychotropics drugs in non-fatal selfpoisoning

    Page :439-439

    G. Mandic-Gajic, T. Zujovic, R. Samardzic, Z. Spiric, B. Miljanovic, M. Preradovic

    
  • ·P03.431 Multi family discussion group in eating disorder integrated treatment

    Page :439-439

    A. Mei, M. Riccio, G. Faragalli, A. Ciocca, S. De Risio

    
  • ·P03.432 Comparison between SCL90R and S.C.I.D. I in eating disorders patients

    Page :440-440

    M. Riccio, G. Faragalli, A. Mei, A. Ciocca, S. De Risio

    
  • ·P03.433 Treatment of somatophorm disorders in Russian' hospitals

    Page :440-440

    V.N. Prokudin, A.P. Muzychenko, P.I. Sharaev, L.L. Khoundanov

    
  • ·P03.434 Psychiatric comorbidity among drug addicts: Evaluation of prevalence rate and creation of a network of intervention

    Page :440-440

    L. Di Furia, F. Scivittaro, M. Rizzo, F. Schifano, M. Sgrò

    
  • ·P03.435 Complex treatment of emergency conditions in patients with drug addiction

    Page :440-441

    N. Epifanova, A. Koukchina, I. Epifanov

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.436 Clinical symptoms among female and male drug-naive schizophrenic patients

    Page :441-441

    B.J. Havaki-Kontaxaki, V.P. Kontaxakis, S.S. Stamouli, C.T. Kolhas, G.N. Christodoulou

    
  • ·P03.437 Are regional suicide rates mirrored in subsequent national political changes?

    Page :441-441

    M. Voracek, A.K. Formann, G. Sonneck

    
  • ·P03.438 An acid test for nostradamus: Total eclipse of the sun 1999 and suicide incidence

    Page :441-441

    M. Voracek, G. Sonneck

    
  • ·P03.439 Suicidal behavior in prison inmates: Prospective Austrian national data 1996–1999

    Page :441-442

    M. Voracek, O. Bemecker, G. Sonneck

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.440 Depressive disorders and anxiety disorders in patients dialysed due to chronic renal insufficency

    Page :442-442

    G. Sikora, A. Klimowicz

    
  • ·P03.441 Influence of alcohol and alcoholism on criminal offences

    Page :442-442

    T. Žarkovic Palijan, M. Kovac, D. Kovacevic

    
  • ·P03.442 Impaired conditional discrimination learning in patients with social phobia

    Page :442-442

    G. Sachs, K. Dantendorfer, P. Anderer, M. Eberstaller, B. Saletu, H. Katschnig

    
  • ·P03.443 ADAS-COG (Alzheimer's Disease Assessment Scale-Cognitive subscale)-validation of the Slovak version

    Page :443-443

    E. Kolibáš, V. Kořínková, V. Novotný, D. Hunáková, K. Vajdičková

    
  • ·P03.444 A study in infertility: Psychodynamic and psychological evaluation of women undergoing IVF treatment

    Page :443-443

    M. Chatziandreou, G. Vaslamatzis, D. Kakatsaki, U. Dafni, D. Loutradis, M. Markidis

    
  • ·P03.445 Personality's features in eating disorders

    Page :443-443

    M. Bel, I. Jódar, M. Márquez, V. Fabregat, D. Palao

    
  • ·P03.446 Adopted image of disease as the basic psychological phenomenon of the therapeutic alliance with schizophrenic and depressive patients

    Page :443-444

    X. Solozhenkina

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.447 Secondary brain damage with HIV/AIDS

    Page :444-444

    J. Potribná, J. Kolčáková

    
  • ·P03.448 Neurasthenia-chronic fatigue syndrome. The basis and the meaning of medication and other therapy

    Page :444-444

    L. Janu, I. Prusa

    
  • ·P03.449 Profile of therapeutic action of mexidol in patients with organic brain injury

    Page :444-444

    I.A. Davydova

    
  • ·P03.450 Pharmachotherapy and psychotherapy of depressive disorders

    Page :444-445

    G.S. Bannikov

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.451 Antidepressants from different chemical groups in treatment of moderate and severe depression: Clinical and neurophysiological actions

    Page :445-445

    A. D'yakonov

    
  • ·P03.452 New approach towards a classification of organic brain disorders according ICD-10

    Page :445-445

    J. Kafka, E. Pálová

    
  • ·P03.453 Features of clinical patterns of suicidal behaviour in mental ill patients with post-traumatic brain lesions

    Page :445-445

    Z.R. Zulkarneeva, R.R. Khamitov

    
  • ·P03.454 Depression reduces the health-related quality of life

    Page :445-445

    S. Simo, K.S. Jouko, T. Tuula

    
  • ·P03.455 Psychiatric disorder in mentally retarded adolescent inpatients

    Page :446-446

    V. Tort-Herrando, M.E. Navarro-Hurtado

    
  • ·P03.457 Artistic production of a group schizophrenic patientes

    Page :446-446

    M. Krsmanović, Č.D. Miljević

    
  • ·P03.458 Behavioral and psychological symptoms of dementia

    Page :446-446

    K. Soltys, L. Bidzan

    
  • ·P03.459 Psychotherapeutic models of anxiety. depressive somatization disorders

    Page :446-446

    V. Solozhenkin, A. Kim

    
  • ·P03.460 Ethnoculturally oriented psychotherapy of anxiety and panic disorders in Kyrgyzstan

    Page :447-447

    V. Solozhenkin, T. Nelubova

    
  • ·P03.461 Dependent behaviors and psychotropic drug consumption

    Page :447-447

    P. Bizouard, S. Nezelof, Y. Taccoen, M. Corcos, J.L. Venisse, F. Perez-Diaz, O. Halfon, G. Loas, F. Lang, M. Flament, Ph. Jeammetz

    
  • ·P03.462 Open trial with milnacipran to assess efficacy, tolerability and quality of life

    Page :447-447

    A. Zoghlami, B. Schmid-Siegel

    
  • ·P03.463 A movement therapy group for mild demented and depressive patients — Description of an intervention

    Page :447-448

    I. Abramovici, N. Ashkenazi

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.464 Atypic antypsychotics in the treatment of both cognitive and behavioural deficiency of dementia

    Page :448-448

    L. Tarricone

    
  • ·P03.465 Pharmacotherapy of the DOC resistant

    Page :448-448

    L. Tarricone

    
  • ·P03.466 Association of apolipoprotein E and alpha2macroglobulin with alzheimer disease in Czech population

    Page :448-448

    A. Howardova, B. Rypackova, R. Jirak

    
  • ·P03.467 Development of the ptsd symptoms under the condition of the specific traumatic event

    Page :448-449

    G. Grbesa, M. Popovic, M. Simonovic

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.468 Modes of adaptation to prolonged stress in individuals with dependent and passive aggressive personality disorders

    Page :449-449

    N. Caran

    
  • ·P03.469 Depression and anxiety in pre-menstrual syndrome

    Page :449-449

    S. Tosic, S. Miljkovic, N. Golubovic

    
  • ·P03.470 Quantitative assessment of war-related stressors and a level of distress: A stuot study

    Page :449-450

    V. Jovic, D. Lecic-Tosevski, D. Savic, G. Knezevic, L. Tenjovic, G. Opacic

    Résumé Résumé Plan Plan

• Symposia

  • ·P03.472 Prognosis of remission in paranoid schizophrenic patients

    Page :450-450

    N.V. Govorin, T.P. Zlova

    
  • ·P03.473 Outcome in panic disorder

    Page :450-450

    S. Gariboldi, C. Cimmino, C. Balista, M.E. Menini, G. Paulillo, M. Amore, C. Maggini

    
  • ·Author index

    Page :451-463

    Résumé Résumé Plan Plan